"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL1614410";"F";"PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)]";"Homo sapiens";"17175";"17193";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1647773";"F";"Cytotoxicity against human HT-29 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL810265";"F";"Compound was tested for antibacterial activity against Staphylococcus aureus ATCC 25923";"Staphylococcus aureus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1280";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1613914";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ";"Homo sapiens";"39332";"39754";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794311";"F";"PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855]";"";"20124";"20420";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL759008";"F";"Compound was evaluated for cytotoxicity against P388 leukemia cell line.";"Mus musculus";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"";"";"";"";"";""
"CHEMBL712035";"F";"Tested for the cytotoxicity (continuous incubation) against L1210 leukemia cells determined by clonogenic assay.";"Mus musculus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL1794352";"F";"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]";"";"59860";"60142";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL702384";"F";"Resistance factor (RF), ratio between the IC50 on the resistant cells and the IC50 on the corresponding sensitive cells of KB cell line";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL1738444";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1477, AID1484]";"Homo sapiens";"56";"58";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL913187";"F";"Antiproliferative activity against drug resistant H69AR cell line expressing MRP1 by Alamar Blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"H69AR";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL1794536";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638]";"";"7413";"7660";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855046";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1738186";"B";"PUBCHEM_BIOASSAY: C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431]";"Salmonidae";"130";"130";"BAO_0000217";"biochemical format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"8015";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL656320";"F";"Cytotoxicity of compound was tested against Capen-1 cell line (pancreatic carcinoma) after incubation for 72 hour";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAPAN-1";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1176776";"F";"Cytotoxicity against human MCF7 cells after 72 hrs by XTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1908289";"A";"Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1614216";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"206";"214";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965578";"B";"Inhibition of mouse brain MAOA";"Mus musculus";"385";"391";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1908083";"A";"Specific activity of expressed human recombinant UGT1A6";"Homo sapiens";"122";"166";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL1614008";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"142";"148";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1777079";"F";"Cytotoxicity against human colchicine-resistant KB-C2 cells after 6 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-C2";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL1954708";"B";"Binding affinity to human pre-hsa-mir-155 miRNA assessed as inhibition of dicer-catalysed (33P)-labelled pre-miRNA processing at 1 mM after 1 hr by PAGE analysis";"Homo sapiens";"12";"13";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1949550";"22257890";"10.1016/j.bmcl.2011.12.103";"2012";"Bioorg Med Chem Lett";"22";"1709";"1711";"";"";"";"";"";""
"CHEMBL1777081";"F";"Cytotoxicity against human K562 cells after 6 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL1794467";"F";"PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878]";"";"1930";"2027";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL705938";"F";"Compound was evaluated for the 50% inhibition of the incorporation of [3H]- thymidine in the RNA (inhibition of synthesis in leukemia L1210 cells)";"Mus musculus";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123251";"3761325";"10.1021/jm00160a047";"1986";"J Med Chem";"29";"2074";"2079";"";"";"";"";"";""
"CHEMBL1764598";"B";"Binding affinity to poly(dAT)2 assessed as change in melting temperature at compound to polynucleotide ratio of 1";"";"14";"14";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1759981";"21439821";"10.1016/j.bmcl.2011.02.106";"2011";"Bioorg Med Chem Lett";"21";"2259";"2263";"";"";"";"";"";""
"CHEMBL1647795";"B";"Inhibition of human recombinant DNA topoisomerase 2alpha-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 20 uM after 30 mins by agarose gel electrophoresis";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1794584";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]";"";"63980";"64461";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909184";"B";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855617";"F";"Antiproliferative activity against P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1794548";"F";"PUBCHEM_BIOASSAY: Counterscreen for activators of insulin-degrading enzyme (IDE): fluorescence-based cell-based high throughput dose response LDH release assay to identify compounds that are cytotoxic to HEK cells or compromise cell membrane permeability. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681]";"Homo sapiens";"231";"231";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909097";"B";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"Sus scrofa";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9823";"CHEMBL3638187";"Heart";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794499";"F";"PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856]";"";"13678";"13785";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697779";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents";"Rodentia";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9989";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL1794445";"F";"PUBCHEM_BIOASSAY: Fluorescence polarization-based cell-based high throughput dose response assay to identify activators of insulin-degrading enzyme (IDE). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681]";"";"231";"231";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909130";"B";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909155";"B";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"5";"5 - Multiple direct protein targets may be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638246";"Spinal cord";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909156";"B";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909148";"B";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909206";"B";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909111";"B";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909089";"B";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909143";"B";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614072";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"159";"166";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909214";"B";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909139";"B";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909162";"B";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909168";"B";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909188";"B";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909192";"B";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909137";"B";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909112";"B";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909211";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909191";"B";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"Bos taurus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9913";"CHEMBL3638197";"Uterus";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909095";"B";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638191";"Lens of camera-type eye";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614079";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ";"Homo sapiens";"22998";"23070";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909215";"B";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909129";"B";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"1321-N1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909177";"B";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"IMR-32";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909181";"B";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909131";"B";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf21";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909132";"B";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909153";"B";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909166";"B";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614531";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ";"Homo sapiens";"9451";"9571";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613995";"F";"PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ]";"Homo sapiens";"6267";"6303";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614474";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a), 463106 (LOPAC Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a)]";"Homo sapiens";"1511";"1511";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL748624";"F";"Evaluated in vitro for antiproliferative activity against NIC-H460 cell lines derived from large cell carcinoma of the lung";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL725379";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 10 mg/kg/day, iv; 0/18";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL730201";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 10 mg/kg/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2166270";"B";"Inhibition of electric eel AChE at 2 mg/ml by Ellman's method";"Electrophorus electricus";"500";"501";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"8005";"";"";"";"";"CHEMBL2163249";"23062825";"10.1016/j.bmc.2012.09.040";"2012";"Bioorg Med Chem";"20";"6669";"6679";"";"";"";"";"";""
"CHEMBL1737902";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355]";"";"75513";"75614";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909185";"B";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909203";"B";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909183";"B";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"Mus musculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"ICR";"DrugMatrix";"10090";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909124";"B";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909136";"B";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909121";"B";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909098";"B";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638251";"Adrenal gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909199";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909109";"B";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909127";"B";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909135";"B";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909141";"B";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614215";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-004. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"206";"215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909171";"B";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909208";"B";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand albino";"DrugMatrix";"9986";"CHEMBL3638205";"Urinary bladder";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909209";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909101";"B";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"T47D";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614521";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]";"Homo sapiens";"6501";"6540";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794580";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"130891";"131175";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL975111";"F";"Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1158125";"17190447";"10.1021/np060273t";"2006";"J Nat Prod";"69";"1711";"1714";"";"";"";"";"";""
"CHEMBL1647793";"B";"Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 5 uM after 30 mins by agarose gel electrophoresis";"Homo sapiens";"2";"2";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL712021";"F";"Compound was tested for its toxicity against doxorubicin resistant human breast cancer cells (MCF-7/ADR).";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL1131304";"9548820";"10.1021/jm970739s";"1998";"J Med Chem";"41";"1306";"1314";"";"";"";"";"";""
"CHEMBL1614174";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ";"Bacillus subtilis";"24077";"24320";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"1423";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613933";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]";"Homo sapiens";"7185";"7272";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613797";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ";"Bacillus anthracis str. A2012";"6269";"6353";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"191218";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076208";"F";"TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells";"";"28";"28";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL2076235";"F";"TP_TRANSPORTER: inhibitory effect of typical BSEP inhibitors (Verapamil & Cyclosporin A) in SK-E2 cells (expressing BSEP)";"";"15";"15";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"SK-E2";"";"CHEMBL2074066";"12739759";"10.1023/a:1023278211849";"2003";"Pharm Res";"20";"537";"544";"";"";"";"";"";""
"CHEMBL702594";"F";"Cytotoxic activity against adriamycin (ADR) resistant L-1210 cell line";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210 (1565)";"";"CHEMBL1128855";"None";"10.1016/0960-894X(95)00067-4";"1995";"Bioorg Med Chem Lett";"5";"593";"596";"";"";"";"";"";""
"CHEMBL1614275";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]";"Giardia intestinalis";"14724";"14961";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"5741";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738397";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485367, AID485368, AID488768]";"Trypanosoma brucei TREU927";"144";"144";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614257";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ";"Homo sapiens";"37649";"37911";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1741322";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1008688";"F";"Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by microtiter plate assay";"Bacillus subtilis";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1423";"";"";"";"";"CHEMBL1148926";"15497950";"10.1021/np049826v";"2004";"J Nat Prod";"67";"1729";"1731";"";"";"";"";"";""
"CHEMBL2345818";"B";"Displacement of SYBR from phage lambda DNA by FID assay";"Enterobacteria phage lambda";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10710";"";"";"";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL872678";"F";"In vitro cytotoxic activity was evaluated using the human uterine sarcoma cell line MES-SA";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL1009005";"F";"Cytotoxicity against human LNCAP cells expressing androgen receptor after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LNCaP";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL1647784";"A";"Cytotoxicity against african green monkey Vero cells after 3 days by MTS assay";"Chlorocebus sabaeus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1692847";"F";"Resistant index, ratio of EC50 for tafenoquine-resistant promastigotes of Leishmania major R4 to EC50 for promastigotes of Leishmania major MHOM/JL/80/Friedlin";"Leishmania major";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5664";"";"";"";"";"CHEMBL1687853";"21199921";"10.1128/aac.01545-10";"2011";"Antimicrob Agents Chemother";"55";"1045";"1052";"";"";"";"";"";""
"CHEMBL2025734";"B";"Inhibition of Topoisomerase 2 assessed as kinetoplast DNA decatenation at 50 uM after 10 mins by electrophoretic analysis";"";"5";"5";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025760";"A";"Drug uptake in human DU145 cell perinuclear region at 1 uM after 4 hrs by confocal microscopic analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL691298";"F";"Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in human prostate cancer HTB-81 cells using MTS assay.";"Homo sapiens";"28";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HTB-81";"";"CHEMBL1133679";"11020285";"10.1021/jm000073t";"2000";"J Med Chem";"43";"3704";"3713";"";"";"";"";"";""
"CHEMBL1908080";"A";"Specific activity of expressed human recombinant UGT1A1";"Homo sapiens";"166";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL719881";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 10 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1613776";"F";"PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ";"Homo sapiens";"4283";"4313";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL756548";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for % increase in life span at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL655115";"F";"Inhibitory activity against CCRF-CEM(human leukemic lymphoblastic) cells in culture.";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1122143";"7057426";"10.1021/jm00344a019";"1982";"J Med Chem";"25";"187";"191";"";"";"";"";"";""
"CHEMBL705937";"F";"Compound was evaluated for the 50% inhibition of the incorporation of [3H]- thymidine in the DNA (inhibition of synthesis in leukemia L1210 cells)";"Mus musculus";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123251";"3761325";"10.1021/jm00160a047";"1986";"J Med Chem";"29";"2074";"2079";"";"";"";"";"";""
"CHEMBL1009006";"F";"Cytotoxicity against human PC3 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL1030895";"F";"Cytotoxicity against human HeLa cells assessed as inhibition of colony formation at 25 ng/ml relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL1794570";"F";"PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681]";"Homo sapiens";"231";"231";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614168";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"98";"103";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL664992";"F";"Compound was tested for antibacterial activity against Corynebacterium diphtheria WSU";"Corynebacterium diphtheriae";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1717";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1804225";"F";"Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human SF268 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL669614";"B";"Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate";"";"109";"185";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"L5178Y";"";"CHEMBL1122587";"6699880";"10.1021/jm00369a019";"1984";"J Med Chem";"27";"347";"357";"";"";"";"";"";""
"CHEMBL767645";"F";"Inhibition of [3H]uridine incorporation into proliferating L1210 cells.";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122652";"6716401";"10.1021/jm00371a014";"1984";"J Med Chem";"27";"638";"645";"";"";"";"";"";""
"CHEMBL1613813";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"205";"215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL727200";"F";"Percent median treated tumor size to that of control tumor size in NYH treatment model in mice (in vivo) after intraperitoneal administration of compound (0.5 mg/kg, number of tumors 8)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1030905";"F";"Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 6.6 mg/kg, ip relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"standard_type:DOSE standard_relation:= standard_value:6.6 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models | Xenograft Oncology Models";"P388 Experimental Leukemia | Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL678201";"F";"Cytotoxicity against EVSA-T tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"EVSA-T";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL703459";"F";"Cytotoxicity against H 226 tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H226";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL2091136";"B";"Inhibition of human topoisomerase 2-mediated [3H]TdR-labeled catenated kinetoplast DNA decatenation after 15 to 30 mins by scintillation counting";"Homo sapiens";"9";"9";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL1105860";"A";"Cytotoxicity against HEK293 cells at 400 nM after 48 hrs by resazurin conversion-based fluorometric assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL1154261";"19739598";"10.1021/np900173d";"2009";"J Nat Prod";"72";"1573";"1578";"";"";"";"";"";""
"CHEMBL968663";"B";"Displacement of ethidium bromide from calf thymus type 1 DNA after 24 hrs by microtiter assay";"Bos taurus";"9";"9";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1150052";"1479377";"10.1021/np50089a004";"1992";"J Nat Prod";"55";"1582";"1587";"";"";"";"";"";""
"CHEMBL2025156";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 72 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2076066";"F";"TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) in MDR1-expressing MDCK cells";"";"9";"9";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2074370";"12134945";"10.1023/a:1016140429238";"2002";"Pharm Res";"19";"765";"772";"";"";"";"";"";""
"CHEMBL1176777";"F";"Cytotoxicity against human NCI-H460 cells after 72 hrs by XTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL2025152";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 48 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL703251";"F";"Dose required to inhibit the DNA synthesis in leukemia L1210 cells";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"";"";"";"";"";""
"CHEMBL758655";"F";"Compound was evaluated for the antitumor efficacy at optimal dose 8 mg/kg against leukemia P388 in mice on day q4d 5, 9, 13.,";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123251";"3761325";"10.1021/jm00160a047";"1986";"J Med Chem";"29";"2074";"2079";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1009004";"F";"Cytotoxicity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL708482";"F";"Antiproliferative activity of compound was tested against melanoma (M-19) human tumor cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"M19-MEL";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL1009001";"F";"Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL855056";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL730204";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 11 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL886158";"B";"Displacement of methyl green from DNA";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1139930";"17428583";"10.1016/j.ejmech.2007.02.014";"2007";"Eur J Med Chem";"42";"1325";"1333";"";"";"";"";"";""
"CHEMBL1100808";"F";"Cytotoxicity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL719310";"F";"Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 11 mg/kg/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL865857";"F";"Mortality in mice with Dox-resistant K562 xenografts in 20 days at 5-10 mg/kg, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL2162206";"B";"Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay";"Human immunodeficiency virus 1";"14";"14";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL2157905";"22695131";"10.1016/j.bmcl.2012.05.041";"2012";"Bioorg Med Chem Lett";"22";"4844";"4848";"";"";"";"";"";""
"CHEMBL1613874";"F";"PUBCHEM_BIOASSAY: Tumor Hsp90 Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)]";"Homo sapiens";"264";"268";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2025280";"B";"Inhibition of HDAC6 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL678203";"F";"Antiproliferative activity of compound was tested against mammary carcinoma (EVSAT) human tumor cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"EVSA-T";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL1613970";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ";"";"5084";"5184";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL748620";"F";"Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in normal human fibroblast (NHF) cells using MTS assay.";"Homo sapiens";"28";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1133679";"11020285";"10.1021/jm000073t";"2000";"J Med Chem";"43";"3704";"3713";"";"";"";"";"";""
"CHEMBL688082";"F";"Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL619959";"F";"Cytotoxicity against A 498 tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A498";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL1285395";"F";"Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay";"Saccharomyces cerevisiae";"66";"66";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"AD1-8u";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL758085";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for tumor free survivors at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL714046";"F";"Tested for its inhibitory activity against human melanoma cells (MEFX 989) using a clonogenic assay at 0.01-1.0 uM";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MEXF989";"";"CHEMBL1150981";"None";"10.1016/S0960-894X(97)00069-3";"1997";"Bioorg Med Chem Lett";"7";"617";"622";"";"";"";"";"";""
"CHEMBL1614349";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"104";"111";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2328698";"F";"Ratio of IC50 for mouse L5178Y cells expressing p-gp to IC50 for mouse L5178Y cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL2321804";"23199479";"10.1016/j.bmc.2012.10.041";"2013";"Bioorg Med Chem";"21";"166";"177";"";"";"";"";"";""
"CHEMBL664952";"B";"Change in thermal denaturation temperature of calf thymus DNA";"Bos taurus";"11";"11";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1122652";"6716401";"10.1021/jm00371a014";"1984";"J Med Chem";"27";"638";"645";"";"";"";"";"";""
"CHEMBL1285393";"F";"Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay";"Saccharomyces cerevisiae";"66";"66";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"AD1-8u";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL681208";"F";"Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 0.8 ug/mL)";"Escherichia coli";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL1121563";"6779008";"10.1021/jm00185a020";"1980";"J Med Chem";"23";"1242";"1244";"";"";"";"";"";""
"CHEMBL662954";"B";"Tested for binding affinity per DNA base pair in rat";"Rattus norvegicus";"5";"5";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL730943";"F";"Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL746886";"F";"Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NHDF";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1738498";"F";"PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399]";"Influenza A virus (A/California/07/2009(H1N1))";"1012";"1013";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"641809";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL811762";"T";"Lethal dose of compound required when administered BALB C mice";"Mus musculus";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1794345";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"170142";"170462";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614554";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ";"Homo sapiens";"1190";"1213";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1100809";"F";"Cytotoxicity against human doxorubicin-resistant K562 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL711354";"F";"Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1030900";"F";"Cytotoxicity against human HeLa cells assessed as inhibition of colony formation relative to control";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL1613876";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-005. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"229";"237";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL879955";"F";"Concentration of drug necessary to reduce by 50% the incorporation of tritiated thymidine in the DNA of actively growing L1210 cells";"Mus musculus";"10";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122183";"7086816";"10.1021/jm00343a004";"1982";"J Med Chem";"25";"18";"24";"";"";"";"";"";""
"CHEMBL1009002";"F";"Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL1697798";"A";"FDA HLAED, alkaline phosphatase increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909122";"B";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909138";"B";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909170";"B";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909142";"B";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1030911";"T";"Toxicity in mouse P388 cells xenografted mouse assessed as induction of death at 4.4 mg/kg, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"standard_type:DOSE standard_relation:= standard_value:4.4 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL1909119";"B";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HT-29";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909120";"B";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909105";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL756922";"F";"Antitumor efficacy at optimal dose of compound was measured against P388 leukemia in mice";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122183";"7086816";"10.1021/jm00343a004";"1982";"J Med Chem";"25";"18";"24";"";"";"";"";"";""
"CHEMBL1804224";"F";"Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human MCF7 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MRC5";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL1030901";"F";"Cytotoxicity against mouse P388 cells";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL1613964";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"89";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614492";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"167";"175";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL811543";"F";"Compound was tested for antibacterial activity against Staph. epidermidis ATCC 12228";"staphylococcus epidermitis";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1282";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL754308";"F";"Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1112635";"F";"Cytotoxicity against human multidrug-resistant KB-C2 cells after 48 hrs by MTT assay";"Homo sapiens";"46";"46";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-C2";"";"CHEMBL1156240";"20363142";"10.1016/j.bmc.2010.02.046";"2010";"Bioorg Med Chem";"18";"2964";"2975";"";"";"";"";"";""
"CHEMBL1613836";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) ";"Homo sapiens";"31975";"32120";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL802171";"B";"Apparent binding affinity to herring sperm DNA at 25 degree Celsius in PBS buffer with pH 7.4";"Clupeidae";"9";"9";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"55118";"";"";"";"";"CHEMBL1121550";"7452665";"10.1021/jm00185a003";"1980";"J Med Chem";"23";"1166";"1170";"";"";"";"";"";""
"CHEMBL3137738";"T";"Comments (NB not yet translated). [column 'COMMENTAIRES' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137736";"T";"Animal toxicity known. [column 'TOXIC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3231602";"F";"Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 2 mg/kg, ip on days 5, 9 and 13 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL749391";"F";"Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NHDF";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1647776";"F";"Cytotoxicity against human HepG2 cells assessed as cell viability at 16 uM after 24 hrs by MTS assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1647777";"F";"Cytotoxicity against human MCF7 cells after 24 hrs by MTS assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1738606";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398]";"Homo sapiens";"13828";"13960";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL650334";"F";"In vitro antiproliferative activity against B16 cell lines";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL661369";"B";"Tested for the binding affinity for DNA by intercalation between adjacent base pairs of the helix.";"Bos taurus";"11";"11";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL693877";"F";"Tested for the cytotoxicity(1 hour incubation) against human colon tumor cell lines (HT 29).";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL1697778";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans";"Homo sapiens";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL1741323";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3418666";"F";"Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL991974";"B";"Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli";"Human immunodeficiency virus 1";"18";"18";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL1158321";"9322359";"10.1021/np9700275";"1997";"J Nat Prod";"60";"884";"888";"";"";"";"";"";""
"CHEMBL710203";"F";"Compound was tested for its toxicity against human breast cancer cells(MCF-7)";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1131304";"9548820";"10.1021/jm970739s";"1998";"J Med Chem";"41";"1306";"1314";"";"";"";"";"";""
"CHEMBL3281270";"U";"Ratio of inhibition of [14C]-uridine incorporation into RNA in mouse L1210 cells to cellular uptake in mouse L1210 cells";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL1613950";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-015. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"188";"196";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL852131";"F";"Relative resistance value of Adriamycin resistant L-1210/L-1210 parental cell line";"";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1128855";"None";"10.1016/0960-894X(95)00067-4";"1995";"Bioorg Med Chem Lett";"5";"593";"596";"";"";"";"";"";""
"CHEMBL688083";"F";"Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1285394";"B";"Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u";"Candida albicans";"66";"66";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5476";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL1614211";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ";"";"36499";"36798";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2390678";"B";"Inhibition of tau K19 (unknown origin) aggregation assessed as inhibition of paired helical filament formation after 10 days by thioflavin S fluorescence assay in presence of heparin";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2385058";"23484434";"10.1021/jm3017317";"2013";"J Med Chem";"56";"4135";"4155";"";"";"";"";"";""
"CHEMBL3137729";"T";"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1105085";"F";"Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"2";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1154817";"19968258";"10.1021/np9006603";"2009";"J Nat Prod";"72";"2192";"2194";"";"";"";"";"";""
"CHEMBL4480806";"U";"Selectivity index, ratio of IC50 for BHK-21 cells to IC50 for mouse 4T1 cells";"";"35";"35";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4480386";"30654237";"10.1016/j.ejmech.2019.01.001";"2019";"Eur J Med Chem";"165";"18";"30";"";"";"";"";"";""
"CHEMBL3137727";"T";"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3284957";"F";"Inhibition of DNA synthesis in mouse L1210 cells preincubated for 3 hrs followed by [3H]-thymidine addition measured after 1 hr by scintillation spectrometric analysis";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"";"";"";"";"";""
"CHEMBL890796";"F";"Cytotoxicity against HOS cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HOS";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL4352916";"F";"Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL1176774";"F";"Cytotoxicity against human NCI-H460 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1176781";"F";"Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human NCI-H460 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1614456";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561978";"F";"PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"97";"98";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL720061";"F";"In vivo growth inhibitory activity was measured against murine P388 leukemia cells as Percent increase in life span at the dose of 2.0 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122143";"7057426";"10.1021/jm00344a019";"1982";"J Med Chem";"25";"187";"191";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL3137731";"T";"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562146";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ";"";"1812";"1824";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL673517";"F";"The compound was evaluated for the growth inhibition of Dx5 cell lines using MTT assay.";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1133378";"10698449";"10.1016/s0960-894x(99)00667-8";"2000";"Bioorg Med Chem Lett";"10";"261";"264";"";"";"";"";"";""
"CHEMBL1100805";"F";"Cytotoxicity against human multidrug resistant KB-C2 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-C2";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL1738442";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]";"Homo sapiens";"90360";"91293";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613897";"F";"PUBCHEM_BIOASSAY: Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]";"";"311";"316";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL635338";"B";"DNA binding dissociation constant as KD";"";"21";"21";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122633";"6708048";"10.1021/jm00370a007";"1984";"J Med Chem";"27";"450";"465";"";"";"";"";"";""
"CHEMBL704011";"F";"Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.5 mg/kg intraperitoneal dose";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210 (1565)";"";"CHEMBL1125096";"2391682";"10.1021/jm00171a011";"1990";"J Med Chem";"33";"2380";"2384";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3215289";"F";"PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity.   (Class of assay: confirmatory) ";"";"437";"511";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909176";"B";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"KAN-TS";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909161";"B";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909151";"B";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614097";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"200";"208";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909108";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909092";"B";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613910";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ";"Homo sapiens";"11728";"11816";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909172";"B";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909179";"B";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909198";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909102";"B";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909154";"B";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697802";"A";"FDA HLAED, gamma-glutamyl transferase (GGT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909194";"B";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076257";"F";"TP_TRANSPORTER: drug resistance in MRP1-expressing HEK293 cells";"";"5";"11";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"";"CHEMBL2074511";"12867490";"10.1124/dmd.31.8.1016";"2003";"Drug Metab Dispos";"31";"1016";"1026";"";"";"";"";"";""
"CHEMBL1614218";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) ";"";"267";"274";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909117";"B";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909096";"B";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909099";"B";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"Bacillus cereus";"871";"1742";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"1396";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256433";"F";"In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 4 mg/kg, ip administered on days 1 to 9 relative to control";"Mus musculus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL1909213";"B";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562038";"F";"PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"229";"230";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"SNU-C1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614466";"F";"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) ), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 2517 (qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)]";"Homo sapiens";"573";"575";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL981353";"F";"Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL2114847";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP. (Class of assay: confirmatory) ";"";"197";"197";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614421";"B";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"Homo sapiens";"49165";"49809";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562152";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ";"";"1822";"1837";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1908292";"B";"Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay";"Canis lupus familiaris";"60";"60";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1614458";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]";"Homo sapiens";"75376";"75927";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2025145";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 24 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2025278";"B";"Inhibition of HDAC1/2 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis";"Homo sapiens";"7";"7";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL719876";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 12(mg/kg)/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2025159";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 72 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL855605";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL3280696";"B";"Induction of Escherichia coli omega enzyme-mediated relaxation of Escherichia coli (RR1) pBR313 closed circular DNA at 40 X 10'-12 mol preincubated for 10 mins followed by enzyme-addition measured after 30 mins by agarose gel electrophoretic analysis";"Escherichia coli";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL3272214";"330857";"10.1021/jm00218a013";"1977";"J Med Chem";"20";"1055";"1059";"";"";"";"";"";""
"CHEMBL3529284";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4399805";"F";"Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL4396939";"31431363";"10.1016/j.bmcl.2019.08.021";"2019";"Bioorg Med Chem Lett";"29";"126617";"126617";"";"";"";"";"";""
"CHEMBL3734567";"B";"Inhibition of Tet-induced Flag-tagged mouse TRPM7 expressed in HEK293 cells assessed as inhibition of channel-mediated cell death in presence of Mg2+ incubated for 24 to 48 hrs by propidium iodide uptake assay";"Mus musculus";"359";"359";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Patent Bioactivity Data";"10090";"";"";"HEK293";"";"CHEMBL3727350";"None";"None";"2014";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL730205";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 12(mg/kg)/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL913186";"F";"Antiproliferative activity against drug sensitive NCI-H69 cell line by Alamar Blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H69";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL855610";"F";"Antiproliferative activity against adriamycin resistant P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL855055";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL4029349";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1613803";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855045";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL3259442";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 16 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:16.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL925478";"F";"Cytotoxicity against human A2780 cells after 72 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1140531";"17890094";"10.1016/j.bmc.2007.07.024";"2007";"Bioorg Med Chem";"15";"7470";"7479";"";"";"";"";"";""
"CHEMBL656151";"F";"Thermal denaturation temperature (Tm) of isolated calf thymus helical DNA was measured";"Bos taurus";"10";"10";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1122183";"7086816";"10.1021/jm00343a004";"1982";"J Med Chem";"25";"18";"24";"";"";"";"";"";""
"CHEMBL913185";"F";"Antiproliferative activity against drug resistant ACHN cell line expressing MDR1 by Alamar Blue assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ACHN";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL719309";"F";"Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 10 mg/kg/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL808655";"B";"Inhibitory activity against telomerase at 50 uM concentration (Compound released from underivatized resin";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1133811";"11591511";"10.1016/s0960-894x(01)00553-4";"2001";"Bioorg Med Chem Lett";"11";"2727";"2730";"";"";"";"";"";""
"CHEMBL981349";"F";"Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL673518";"F";"The compound was evaluated for the growth inhibition of Dx5 w/PSC cell lines using MTT assay.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1133378";"10698449";"10.1016/s0960-894x(99)00667-8";"2000";"Bioorg Med Chem Lett";"10";"261";"264";"";"";"";"";"";""
"CHEMBL1738194";"B";"PUBCHEM_BIOASSAY: C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431]";"Human herpesvirus 8";"201";"201";"BAO_0000217";"biochemical format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"37296";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614117";"F";"PUBCHEM_BIOASSAY: qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"Homo sapiens";"167";"169";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697801";"A";"FDA HLAED, lactate dehydrogenase (LDH) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1613785";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"227";"237";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614166";"B";"PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ";"";"34209";"34246";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614267";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells. (Class of assay: confirmatory) ";"";"120";"127";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4420582";"F";"Ratio of cytotoxic IC50 for human THP1 cells with constitutively expressing high SAMHD1 expression to cytotoxic IC50 for parental human THP1 cells expressing low SAMHD1 expression";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613967";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"178";"186";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614364";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ";"Homo sapiens";"11958";"12273";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909307";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909315";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL855057";"F";"Relative fold, IC50 in absence to presence of verapamil in multidrug resistant P388 cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL4194064";"F";"Cytotoxicity in human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4190345";"28923382";"10.1016/j.ejmech.2017.09.009";"2017";"Eur J Med Chem";"140";"141";"154";"";"";"";"";"";""
"CHEMBL4194067";"A";"Cytotoxicity in human HEK293 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL4190345";"28923382";"10.1016/j.ejmech.2017.09.009";"2017";"Eur J Med Chem";"140";"141";"154";"";"";"";"";"";""
"CHEMBL844595";"F";"Ratio of the extracellular cytotoxicities against MDA MB 361(mammary carcinoma cell line) expressing LacZ and carboxypeptidase stCPG2 of the prodrug.; Not available";"";"2";"2";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1132269";"10395490";"10.1021/jm980696v";"1999";"J Med Chem";"42";"2485";"2489";"";"";"";"";"";""
"CHEMBL3231202";"T";"Cardiotoxicity in rat assessed as minimum cumulative drug dose causing electrocardiographic changes";"Rattus norvegicus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL713919";"F";"In vitro cytotoxic activity was evaluated using the MES-SA multidrug-resistant subline MES-SA/Dx5";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL1804223";"F";"Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human NCI-H460 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL1006410";"F";"Induction of apoptotic activity in human KB cells at 1 uM after 24 hrs";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1156629";"18680275";"10.1021/jm8003366";"2008";"J Med Chem";"51";"5052";"5063";"";"";"";"";"";""
"CHEMBL981352";"F";"Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL890795";"F";"Cytotoxicity against HeLa cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL4480803";"F";"Cytotoxicity against mouse CT26.WT cells after 72 hrs by MTT assay";"Mus musculus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CT26.WT";"";"CHEMBL4480386";"30654237";"10.1016/j.ejmech.2019.01.001";"2019";"Eur J Med Chem";"165";"18";"30";"";"";"";"";"";""
"CHEMBL3253427";"F";"Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]thymidine incorporation";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244343";"490537";"10.1021/jm00194a007";"1979";"J Med Chem";"22";"922";"926";"";"";"";"";"";""
"CHEMBL3252590";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3253040";"T";"Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL988383";"F";"Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP";"Rattus norvegicus";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL987566";"B";"Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL3231196";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1613886";"A";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]";"Homo sapiens";"6513";"6846";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614092";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-019. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"185";"194";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL808433";"B";"Inhibitory activity against telomerase at 50 uM concentration (Compound released from DNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3)";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1133811";"11591511";"10.1016/s0960-894x(01)00553-4";"2001";"Bioorg Med Chem Lett";"11";"2727";"2730";"";"";"";"";"";""
"CHEMBL824120";"F";"Thermal denaturation for stabilization of helical DNA by the compound";"";"4";"4";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"";"";"";"";"";""
"CHEMBL1794524";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ";"";"384";"429";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1100807";"F";"Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL1614250";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"Homo sapiens";"20446";"20646";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL641184";"F";"Cytotoxic activity against wild type AML-2 leukemia cell line was determined";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"OCI-AML2";"";"CHEMBL1136495";"14643344";"10.1016/j.bmcl.2003.09.001";"2003";"Bioorg Med Chem Lett";"13";"4451";"4454";"";"";"";"";"";""
"CHEMBL641183";"F";"Cytotoxic activity against DX-100: doxorubicin (100 ng/mL) resistant AML-2 cell line was determined";"";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"OCI-AML2";"";"CHEMBL1136495";"14643344";"10.1016/j.bmcl.2003.09.001";"2003";"Bioorg Med Chem Lett";"13";"4451";"4454";"";"";"";"";"";""
"CHEMBL709131";"F";"Evaluated in vitro for antiproliferative activity against MCF-7 cell lines model of hormone dependent breast cancer";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL1738588";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]";"Homo sapiens";"94040";"94083";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964055";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ";"";"251";"251";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1741325";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL773701";"F";"Compound was evaluated for augmentation of rat liver microsomal oxygen consumption relative to doxorubicin";"Rattus norvegicus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"CHEMBL3559723";"Liver";"";"Microsomal";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"";"";"";"";"";""
"CHEMBL1614108";"A";"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]";"Homo sapiens";"6513";"6846";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614067";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"Homo sapiens";"2514";"2577";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909134";"B";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909086";"B";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL865223";"F";"Increase in the level of drug efflux in Dox-resistant K562 cells in presence of cyclosporine over its absence";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL1909118";"B";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HUVEC";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1008687";"F";"Cytotoxicity against mouse NS1 cells after 72 hrs by microtiter plate assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NS1";"";"CHEMBL1148926";"15497950";"10.1021/np049826v";"2004";"J Nat Prod";"67";"1729";"1731";"";"";"";"";"";""
"CHEMBL867075";"F";"Cytotoxicity against Dox-resistant K562 cells by MTS at 1 uM and in absence of cyclosporine";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL3231209";"T";"Genotoxicity in Salmonella typhimurium TA100 assessed as number of revertants by Ames test";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA100";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL1909190";"B";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909158";"B";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909114";"B";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909174";"B";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1646855";"F";"Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1641525";"21109433";"10.1016/j.bmcl.2010.10.138";"2011";"Bioorg Med Chem Lett";"21";"366";"372";"";"";"";"";"";""
"CHEMBL1647775";"F";"Cytotoxicity against human HepG2 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1909196";"B";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"Rheumatoid synovial fibroblasts";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909090";"B";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909128";"B";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114788";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ";"Homo sapiens";"103470";"103901";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737978";"F";"PUBCHEM_BIOASSAY: 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431]";"Homo sapiens";"165";"165";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285231";"T";"Acute toxicity in mouse allografted with mouse P388 cells assessed as survival less than 5 days at 0.06 to 4 mg/kg, ip qd";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:None standard_value:None standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL2114924";"F";"PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ";"Homo sapiens";"5181";"5185";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1647779";"F";"Cytotoxicity against human HepG2 cells after 24 hrs by MTS assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL2114875";"F";"PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1: Hit Validation. (Class of assay: confirmatory) ";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613904";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-026. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"146";"154";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL890794";"F";"Cytotoxicity against human G361 cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-361";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL2114914";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP. (Class of assay: confirmatory) ";"";"172";"172";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1009003";"F";"Cytotoxicity against human HRT18 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HRT-18 cell line";"";"CHEMBL1150119";"12141872";"10.1021/np010569t";"2002";"J Nat Prod";"65";"1045";"1048";"";"";"";"";"";""
"CHEMBL804095";"F";"Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-MEL-28";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL810266";"F";"Compound was tested for antibacterial activity against Staphylococcus aureus ATCC 9144";"Staphylococcus aureus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1280";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL740462";"F";"Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 4 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P-388";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL653981";"F";"Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 24 hour";"Cricetulus griseus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL633721";"P";"Partition coefficient (logP)";"";"9";"9";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122587";"6699880";"10.1021/jm00369a019";"1984";"J Med Chem";"27";"347";"357";"";"";"";"";"";""
"CHEMBL704012";"F";"Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.5 mg/kg ip dose";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210 (1565)";"";"CHEMBL1124896";"2391681";"10.1021/jm00171a010";"1990";"J Med Chem";"33";"2375";"2379";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL813733";"B";"Inhibitory activity against trypsin at 10e-5 M; NI = no inhibition";"";"13";"13";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1126272";"1322986";"10.1021/jm00093a008";"1992";"J Med Chem";"35";"2768";"2771";"";"";"";"";"";""
"CHEMBL1614356";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-017. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"181";"191";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1647774";"F";"Cytotoxicity against human HT-29 cells assessed as cell viability at 20 uM after 24 hrs by MTS assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1614393";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"186";"194";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL975113";"F";"Cytotoxicity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1158125";"17190447";"10.1021/np060273t";"2006";"J Nat Prod";"69";"1711";"1714";"";"";"";"";"";""
"CHEMBL844606";"F";"Ratio of the intracellular cytotoxicities against MDA MB 361(mammary carcinoma cell line) expressing LacZ (beta-galactosidase). between prodrug and drug.; Not available";"";"1";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1132269";"10395490";"10.1021/jm980696v";"1999";"J Med Chem";"42";"2485";"2489";"";"";"";"";"";""
"CHEMBL821052";"F";"Concentration inhibiting [3H]TdR incorporation in Yoshida sarcoma tumor cells in vitro in rats";"Rattus norvegicus";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"YOSHIDA";"";"CHEMBL1126272";"1322986";"10.1021/jm00093a008";"1992";"J Med Chem";"35";"2768";"2771";"";"";"";"";"";""
"CHEMBL1613853";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"147";"156";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963940";"F";"PUBCHEM_BIOASSAY: Biochemical firefly luciferase enzyme assay for NPC. (Class of assay: confirmatory) ";"";"402";"416";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL658166";"F";"Tested for the cytotoxicity (continuous incubation) against human colon tumor cell lines (colon 4)determined by clonogenic assay.";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL1614361";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ";"Homo sapiens";"16181";"16328";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1105917";"F";"Cytotoxicity against human HT-29 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"2";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1154817";"19968258";"10.1021/np9006603";"2009";"J Nat Prod";"72";"2192";"2194";"";"";"";"";"";""
"CHEMBL816276";"F";"Cytotoxicity of compound was tested against UCLA P-3 cell line (lung carcinoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UCLA P-3";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL882419";"F";"Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 72 hour";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL690452";"F";"Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 72 hour";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HMEC";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1613838";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"21944";"21990";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL810787";"F";"Compound was tested for antibacterial activity against Strep. pyogenes ATCC 19615";"Streptococcus pyogenes";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1314";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1250925";"B";"Binding affinity to histone H1 containing chromatin in chicken erythroleukemic cells mononucleosomes transformed with Marek's virus by Scatchard plot analysis";"Gallus gallus";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9031";"";"";"";"";"CHEMBL1250493";"20698509";"10.1021/jm1007853";"2010";"J Med Chem";"53";"6457";"6465";"";"";"";"";"";""
"CHEMBL1737904";"F";"PubChem BioAssay. qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay. (Class of assay: confirmatory) ";"Homo sapiens";"138";"140";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1100810";"F";"Cytotoxicity against human COLO205 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 205";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL2092593";"F";"HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection";"Plasmodium falciparum";"13";"13";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"3D7";"Harvard Malaria Screening";"5833";"";"";"";"";"CHEMBL2092589";"22586124";"10.1073/pnas.1118370109";"2012";"Proc Natl Acad Sci U S A";"109";"8511";"8516";"";"";"";"";"";""
"CHEMBL2078487";"F";"TP_TRANSPORTER: intracellular accumulation in Bsep-expressing LLC-PK1 cells";"";"7";"7";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074223";"10617675";"None";"2000";"Mol Pharmacol";"57";"24";"35";"";"";"";"";"";""
"CHEMBL2114840";"F";"PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay. (Class of assay: confirmatory) ";"";"201";"210";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114835";"F";"PubChem BioAssay. qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion. (Class of assay: confirmatory) ";"Homo sapiens";"321";"329";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114824";"F";"PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1: Hit Validation using Tamra Binding. (Class of assay: confirmatory) ";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL692227";"F";"Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 72 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL706992";"F";"Tested for its inhibitory activity against xenograft (LXFL 529/11, lung, large cell) using a clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LXFL 529/11";"";"CHEMBL1150981";"None";"10.1016/S0960-894X(97)00069-3";"1997";"Bioorg Med Chem Lett";"7";"617";"622";"";"";"";"";"";""
"CHEMBL2345827";"F";"Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL3057679";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.05 to 0.4 uM";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL1613947";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-009. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"182";"191";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614441";"F";"PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ";"Mus musculus";"36283";"36493";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10090";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL884012";"F";"Antiproliferative activity of compound was tested against renal cancer (A-498) human tumor cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A498";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL701519";"F";"Antiproliferative activity of compound was tested against ovarian carcinoma (IGROV) human tumor cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"IGROV-1";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL730203";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 11 mg/kg/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL758540";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for total dose at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1176773";"F";"Cytotoxicity against human MCF7 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1176783";"F";"Cytotoxicity against human K562 cells after 72 hrs by XTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL721404";"F";"Percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 10 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL719882";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 11 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL691416";"F";"Cytotoxicity against M19 tumor cell line";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL719875";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 11 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL719874";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 10 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1738184";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]";"Homo sapiens";"77876";"78260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697797";"A";"FDA HLAED, liver enzyme composite activity";"Homo sapiens";"486";"1470";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1697780";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents";"";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL725384";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 12(mg/kg)/day, sc; 3/36";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL1647783";"A";"Cytotoxicity against human CRL7761 cells after 3 days by MTS assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL711353";"F";"Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL821436";"F";"Ratio of DNA relaxation times by topoisomerase in presence of 20 uM of compound (t1/e(+drug) / t 1/e(-drug)); Complete inhibition";"";"3";"3";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127472";"7932544";"10.1021/jm00045a026";"1994";"J Med Chem";"37";"3191";"3194";"";"";"";"";"";""
"CHEMBL1613942";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"166";"173";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737991";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402]";"Homo sapiens";"51377";"51656";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL641182";"F";"Cytotoxic activity against D100 daunorubicin (100 nM) resistant AML-2 cell line was determined";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"OCI-AML2";"";"CHEMBL1136495";"14643344";"10.1016/j.bmcl.2003.09.001";"2003";"Bioorg Med Chem Lett";"13";"4451";"4454";"";"";"";"";"";""
"CHEMBL653319";"F";"In vitro growth inhibitory activity against CCRF-CEM (human lymphoblastic leukemic) cells.";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1122048";"6951049";"10.1021/jm00346a027";"1982";"J Med Chem";"25";"478";"481";"";"";"";"";"";""
"CHEMBL914271";"F";"Antiproliferative activity against drug resistant Messa/DX5 cell line expressing MDR1 by Alamar Blue assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL925477";"F";"Cytotoxicity against human A2780/ADR cells after 72 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780 ADR";"";"CHEMBL1140531";"17890094";"10.1016/j.bmc.2007.07.024";"2007";"Bioorg Med Chem";"15";"7470";"7479";"";"";"";"";"";""
"CHEMBL2114784";"F";"PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ";"Homo sapiens";"53812";"54032";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909087";"B";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909160";"B";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909180";"B";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909100";"B";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614146";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) ";"Homo sapiens";"31975";"32120";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909106";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1030910";"T";"Toxicity in mouse P388 cells xenografted mouse assessed as induction of death at 2.9 mg/kg, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"standard_type:DOSE standard_relation:= standard_value:2.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL1909200";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909104";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909197";"B";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909201";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614049";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-007. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"178";"186";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909210";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL865897";"F";"Drug resistance index, ratio of IC50 in Dox-resistant K562 cells over Dox-sensitive cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL1909202";"B";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909150";"B";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa S3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909152";"B";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4399807";"F";"Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4396939";"31431363";"10.1016/j.bmcl.2019.08.021";"2019";"Bioorg Med Chem Lett";"29";"126617";"126617";"";"";"";"";"";""
"CHEMBL2076093";"F";"TP_TRANSPORTER: transepithelial transport of Hoechst 33342 in the presence of Daunorubicin (Daunomycin) at a concentration of 80uM in MDR1-expressing MDCK cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2074322";"15067695";"10.1002/jps.20046";"2004";"J Pharm Sci";"93";"1185";"1194";"";"";"";"";"";""
"CHEMBL1613919";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 16 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"98";"103";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252983";"T";"Mutagenicity in Salmonella typhimurium TA98 assessed as number of revertants by Ames test in presence of microsomal activation";"Salmonella enterica subsp. enterica serovar Typhimurium";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3252985";"A";"Toxicity in Salmonella typhimurium TA98 assessed as concentration required to cause mortality per plate";"Salmonella enterica subsp. enterica serovar Typhimurium";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3254471";"B";"Binding affinity to calf thymus DNA by spectral analysis";"Bos taurus";"7";"7";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"";"";"";"";"";""
"CHEMBL3254892";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1.56 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:1.56 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3254893";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3214913";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ";"";"4591";"5133";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794560";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ";"";"447";"493";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL874167";"F";"The compound was tested for extracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of stCPG2 prodrug";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-361";"";"CHEMBL1132269";"10395490";"10.1021/jm980696v";"1999";"J Med Chem";"42";"2485";"2489";"";"";"";"";"";""
"CHEMBL1613800";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]";"Homo sapiens";"6916";"7035";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909314";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1738574";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388]";"Homo sapiens";"2188";"2190";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL681215";"F";"Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 6.2 ug/mL); Toxic to culture";"Escherichia coli";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL1121563";"6779008";"10.1021/jm00185a020";"1980";"J Med Chem";"23";"1242";"1244";"";"";"";"";"";""
"CHEMBL3232248";"A";"Toxicity in Salmonella typhimurium TA1537 assessed as growth inhibition after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"30";"30";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA1537";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL1614486";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-023. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"140";"146";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL665560";"B";"Binding affinity to Calf thymus DNA type XV; value ranges from 4E6 - 6E6 M-1";"Bos taurus";"1";"1";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1151523";"None";"10.1016/0960-894X(95)00070-A";"1995";"Bioorg Med Chem Lett";"5";"547";"550";"";"";"";"";"";""
"CHEMBL730206";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 12(mg/kg)/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL860573";"F";"Cytotoxicity against drug-sensitive K562 cell line by MTS assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1138154";"16509594";"10.1021/jm050916m";"2006";"J Med Chem";"49";"1792";"1799";"";"";"";"";"";""
"CHEMBL867073";"F";"Cytotoxicity against Dox-resistant K562 cells by MTS at 1 uM and in presence of cyclosporine";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL656158";"F";"Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAPAN-1";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL705343";"F";"In vitro cytotoxicity using human epidermoid carcinoma (KB-A1) cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1129201";"None";"10.1016/0960-894X(96)00457-X";"1996";"Bioorg Med Chem Lett";"6";"2473";"2476";"";"";"";"";"";""
"CHEMBL2092591";"T";"HARVARD: Cytotoxicity in HepG2 cell line";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Harvard Malaria Screening";"9606";"";"";"HepG2";"";"CHEMBL2092589";"22586124";"10.1073/pnas.1118370109";"2012";"Proc Natl Acad Sci U S A";"109";"8511";"8516";"";"";"";"";"";""
"CHEMBL1614528";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"171";"180";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909204";"B";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909147";"B";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909144";"B";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL703252";"F";"Dose required to inhibit the RNA synthesis in leukemia L1210 cells";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"";"";"";"";"";""
"CHEMBL1794364";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ";"";"346";"396";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL760514";"F";"Growth Inhibition of P388/0 cell lines.";"Mus musculus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1133092";"10669575";"10.1021/jm990498j";"2000";"J Med Chem";"43";"475";"487";"";"";"";"";"";""
"CHEMBL1112634";"F";"Cytotoxicity against human KB cells after 48 hrs by MTT assay";"Homo sapiens";"46";"46";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1156240";"20363142";"10.1016/j.bmc.2010.02.046";"2010";"Bioorg Med Chem";"18";"2964";"2975";"";"";"";"";"";""
"CHEMBL968662";"B";"Displacement of methyl green from DNA after 24 hrs by microtiter assay";"";"10";"10";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1150052";"1479377";"10.1021/np50089a004";"1992";"J Nat Prod";"55";"1582";"1587";"";"";"";"";"";""
"CHEMBL2076530";"F";"TP_TRANSPORTER: growth inhibition in hMRP1-expressing tobacco";"Nicotiana tabacum";"2";"2";"BAO_0000218";"organism-based format";"8";"8 - Homologous single protein target assigned";"(cultivar) Samsun NN";"TP-search Transporter Database";"4097";"";"";"";"";"CHEMBL2073829";"16830181";"10.1007/s11103-006-0024-9";"2006";"Plant Mol Biol";"61";"491";"503";"";"";"";"";"";""
"CHEMBL1692848";"F";"Antileishmanial activity against tafenoquine-resistant promastigotes of Leishmania major R4 assessed as inhibition of parasite growth after 72 hrs by MTT assay";"Leishmania major";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"R4";"Scientific Literature";"5664";"";"";"";"";"CHEMBL1687853";"21199921";"10.1128/aac.01545-10";"2011";"Antimicrob Agents Chemother";"55";"1045";"1052";"";"";"";"";"";""
"CHEMBL761354";"F";"Antitumor activity in mice against leukemia P388 cells at 1.4 uM/kg was expressed as ratio of average survival time";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1121745";"7310810";"10.1021/jm00143a014";"1981";"J Med Chem";"24";"1333";"1337";"";"";"";"";"";""
"CHEMBL1250926";"B";"Binding affinity to histone H1 depleted chromatin in chicken erythroleukemic cells mononucleosomes transformed with Marek's virus by Scatchard plot analysis";"Gallus gallus";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9031";"";"";"";"";"CHEMBL1250493";"20698509";"10.1021/jm1007853";"2010";"J Med Chem";"53";"6457";"6465";"";"";"";"";"";""
"CHEMBL1614234";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ]";"Rattus norvegicus";"11394";"11448";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614249";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]";"Equus caballus";"42059";"42303";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9796";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1692849";"F";"Antileishmanial activity against wild type promastigotes of Leishmania major MHOM/JL/80/Friedlin assessed as inhibition of parasite growth after 72 hrs by MTT assay";"Leishmania major";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"MHOM/JL/80/Friedlin";"Scientific Literature";"5664";"";"";"";"";"CHEMBL1687853";"21199921";"10.1128/aac.01545-10";"2011";"Antimicrob Agents Chemother";"55";"1045";"1052";"";"";"";"";"";""
"CHEMBL1908285";"A";"Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL879051";"F";"Cytotoxicity against IGROV tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"IGROV-1";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL4352920";"F";"Cytostatic activity against human HCT116 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL658165";"F";"Tested for the cytotoxicity(1 hour incubation) against human colon tumor cell lines colon 4).";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL1738312";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]";"Homo sapiens";"55525";"55724";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614231";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-002. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"143";"150";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL752559";"F";"Evaluated in vitro for antiproliferative activity against NYH cell lines derived from small cell lung cancer";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL975112";"F";"Cytotoxicity against human PC-3 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1158125";"17190447";"10.1021/np060273t";"2006";"J Nat Prod";"69";"1711";"1714";"";"";"";"";"";""
"CHEMBL690289";"F";"In vitro inhibitory concentration against proliferation of HL60R cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL1614427";"F";"PUBCHEM_BIOASSAY: 14-3-3 protein interaction modulators Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 422 (Primary screen preceding this dose response confirmation assay.)]";"Homo sapiens";"52";"52";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL662299";"F";"Effect on cross resistance of chinese hamster cells resistant to Actinomycin D.";"Cricetulus griseus";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10029";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL662786";"B";"Inhibitory concentration against Clostridium histolyticum Collagenase";"Clostridium histolyticum";"12";"12";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"1498";"";"";"";"";"CHEMBL1126272";"1322986";"10.1021/jm00093a008";"1992";"J Med Chem";"35";"2768";"2771";"";"";"";"";"";""
"CHEMBL2114782";"F";"PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay. (Class of assay: confirmatory) ";"";"167";"176";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL653982";"F";"Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 72 hour";"Cricetulus griseus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL747430";"F";"Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 2 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P-388";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2345814";"A";"Cellular uptake in mouse DA-3 cell nucleus at 10 uM after 30 mins by DRAQ5 deep red staining-based confocal microscopic analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"DA-3";"Nucleus";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL2114849";"F";"PubChem BioAssay. qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"191";"226";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529286";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL2025752";"B";"Inhibition of HDAC in human DU145 cells assessed as upregulation of p21 expression at 5 times IC50 concentration after 4 hrs by Western blot analysis relative to control";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2114890";"F";"PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"1142";"1339";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1030904";"F";"Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 4.4 mg/kg, ip relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"standard_type:DOSE standard_relation:= standard_value:4.4 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models | Xenograft Oncology Models";"P388 Experimental Leukemia | Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL725382";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 11 mg/kg/day, sc; 3/37";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL721403";"F";"Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 12(mg/kg)/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL651225";"F";"Compound was tested for antibacterial activity against Bacillus cereus WSU-60";"Bacillus cereus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1396";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1105916";"F";"Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"2";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1154817";"19968258";"10.1021/np9006603";"2009";"J Nat Prod";"72";"2192";"2194";"";"";"";"";"";""
"CHEMBL1613829";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]";"Homo sapiens";"4515";"4620";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL739124";"F";"Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as Mean tumor volume by day 30";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL939587";"U";"Resistance index, ratio of IC50 for mouse NIH/3T3 cells expressing MDR1 to IC50 for wild type mouse NIH/3T3 cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL1152290";"18954040";"10.1021/jm800403b";"2008";"J Med Chem";"51";"7132";"7143";"";"";"";"";"";""
"CHEMBL825138";"F";"Cytotoxicity against K562 leukemia cell line done for 72 hr at 37 degree C with compound in MTS assay";"Homo sapiens";"7";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1145165";"16078845";"10.1021/jm050144u";"2005";"J Med Chem";"48";"5269";"5278";"";"";"";"";"";""
"CHEMBL1176780";"F";"Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human MCF7 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL758428";"F";"Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 24 hour";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL804094";"F";"Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-MEL-28";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL747435";"F";"T/C of median tumor volumes when 3 mg/kg/dose of compound was given to BALB/c mice bearing sc M109 on days 3 and 6 (iv) after inoculation (control ~2000 mm**3)";"Mus musculus";"10";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1908291";"B";"Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM";"Spodoptera frugiperda";"60";"60";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"7108";"";"";"Sf9";"Membrane";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1614281";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ";"Homo sapiens";"12194";"12285";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL706240";"F";"In vitro cytotoxic activity was evaluated using the murine leukemia L1210 cell line";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL1614477";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-011. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"161";"170";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL858438";"P";"Partition coefficient (log P) was the log of ratio of concentration in octanol / water partitioned concentration in phosphate buffer at pH 7.4.";"";"10";"10";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122652";"6716401";"10.1021/jm00371a014";"1984";"J Med Chem";"27";"638";"645";"";"";"";"";"";""
"CHEMBL1070375";"F";"Growth inhibition of human NCI60 cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI60";"";"CHEMBL1157691";"19944612";"10.1016/j.bmc.2009.11.012";"2010";"Bioorg Med Chem";"18";"124";"133";"";"";"";"";"";""
"CHEMBL1777076";"F";"Cytotoxicity against human KB cells after 6 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL730942";"F";"Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1741324";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1017692";"F";"Induction of apoptosis in multidrug resistant human HL60 cells after 48 hrs";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1154463";"18339455";"10.1016/j.ejmech.2008.01.007";"2008";"Eur J Med Chem";"43";"2386";"2394";"";"";"";"";"";""
"CHEMBL1777080";"F";"Cytotoxicity against human doxorubicin-resistant K562 cells after 6 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL1176782";"F";"Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human SF268 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1794308";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]";"Homo sapiens";"61908";"62243";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2077585";"F";"TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicles from SR3A cells";"";"4";"4";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"SR3A";"Membrane vesicle";"CHEMBL2073916";"9647783";"10.1006/bbrc.1998.8887";"1998";"Biochem Biophys Res Commun";"247";"859";"863";"";"";"";"";"";""
"CHEMBL1030897";"F";"Cytotoxicity against human HeLa cells assessed as colony formation at 6.2 ng/ml relative to control";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL3529281";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL1030902";"F";"Cytotoxicity against doxorubicin resistant mouse P388 cells";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL1794358";"B";"PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442]";"";"231";"231";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1647785";"A";"Cytotoxicity against mouse NIH/3T3 cells after 3 days by MTS assay";"Mus musculus";"11";"11";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL1614236";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ";"Influenza A virus (A/WSN/1933(H1N1))";"32268";"32314";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"382835";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909116";"B";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909140";"B";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909207";"B";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613890";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-003. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"151";"159";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909189";"B";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HIT-T15";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL749525";"F";"Concentration of substrate at which the amount of total cytochrome c reduction is decreased by 10%";"Equus caballus";"1";"1";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"9796";"";"";"";"";"CHEMBL1126673";"8421288";"10.1021/jm00053a005";"1993";"J Med Chem";"36";"38";"41";"";"";"";"";"";""
"CHEMBL871855";"F";"Antiproliferative activity of compound was tested against bladder carcinoma (T-24) human tumor cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T-24";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL1614518";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-025. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"133";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL740467";"F";"Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 8 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P-388";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL758083";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for median day of death at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL845198";"F";"Inhibitory concentration in presence of MDR inhibitor XR-9576";"";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL706689";"F";"Compound was evaluated for cytotoxicity against L1210 murine leukemia cells";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126457";"None";"10.1016/S0960-894X(00)80625-3";"1992";"Bioorg Med Chem Lett";"2";"1093";"1096";"";"";"";"";"";""
"CHEMBL730202";"F";"Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 10 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1647772";"F";"Cytotoxicity against human MCF7 cells assessed as cell viability at 20 uM after 24 hrs by MTS assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL2075747";"F";"TP_TRANSPORTER: inhibition of LTC4 uptake(LTC4: 0.05 uM, Daunorubicin: 30 uM) in membrane vesicles from SR3A cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"SR3A";"Membrane vesicle";"CHEMBL2073916";"9647783";"10.1006/bbrc.1998.8887";"1998";"Biochem Biophys Res Commun";"247";"859";"863";"";"";"";"";"";""
"CHEMBL936123";"B";"Inhibition of synthetic amyloid beta-42 oligomerization by ELISA";"";"27";"27";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1143831";"17284452";"10.1074/jbc.m608207200";"2007";"J Biol Chem";"282";"10311";"10324";"";"";"";"";"";""
"CHEMBL936122";"B";"Inhibition of synthetic amyloid beta42 oligomer formation by Western blot";"";"19";"19";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1143831";"17284452";"10.1074/jbc.m608207200";"2007";"J Biol Chem";"282";"10311";"10324";"";"";"";"";"";""
"CHEMBL865226";"F";"Cytotoxicity against Dox-resistant K562 cells by MTS";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL711225";"F";"In vitro antiproliferative activity against Lewis cell lines";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL3232569";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.39 mg/kg, ip administered as qd for 1 to 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:0.39 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1804213";"F";"Anticancer activity against human MCF7 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL3231213";"F";"Inhibition of DNA synthesis in mouse L1210 cells";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL2166271";"B";"Inhibition of horse BChE at 2 mg/ml by Ellman's method";"Equus caballus";"500";"501";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9796";"";"";"";"";"CHEMBL2163249";"23062825";"10.1016/j.bmc.2012.09.040";"2012";"Bioorg Med Chem";"20";"6669";"6679";"";"";"";"";"";""
"CHEMBL2025146";"F";"Cytostatic activity against human MCF7 cells after 4 days by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL1909091";"B";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697799";"A";"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL689641";"F";"In vitro concentration required to induce apoptosis in HL60 cells";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL1909187";"B";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL705941";"F";"Concentration of drug necessary to reduce by 50% the incorporation of tritiated uridine in the RNA of actively growing L1210 cells.";"Mus musculus";"10";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122183";"7086816";"10.1021/jm00343a004";"1982";"J Med Chem";"25";"18";"24";"";"";"";"";"";""
"CHEMBL1909103";"B";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909123";"B";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Erythrocyte";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909157";"B";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909167";"B";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909175";"B";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"SK-N-MC";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1908086";"A";"Specific activity of expressed human recombinant UGT1A9";"Homo sapiens";"122";"141";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL2114927";"F";"PubChem BioAssay. qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay. (Class of assay: confirmatory) ";"Homo sapiens";"176";"176";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078578";"F";"TP_TRANSPORTER: intracellular accumulation in MDR1-expressing LLC-PK1 cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074223";"10617675";"None";"2000";"Mol Pharmacol";"57";"24";"35";"";"";"";"";"";""
"CHEMBL1614342";"F";"PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"18552";"18602";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076219";"F";"TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells";"";"22";"22";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Sf9";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL758711";"B";"Inhibition of Pancreatic elastase at 10e-5 M; NI means no inhibition";"Sus scrofa";"12";"12";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL1126272";"1322986";"10.1021/jm00093a008";"1992";"J Med Chem";"35";"2768";"2771";"";"";"";"";"";""
"CHEMBL710063";"F";"Resistance factor (RF), ratio between the IC50 on the resistant cells and the IC50 on the corresponding sensitive cells of MES cell line";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-MES-1";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL713477";"F";"In vivo screening in M109 syngeneic solid mouse tumor model (i.p.)";"Mus musculus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"M109";"";"CHEMBL1133092";"10669575";"10.1021/jm990498j";"2000";"J Med Chem";"43";"475";"487";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL855609";"F";"Antiproliferative activity against MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL2184161";"B";"Activity of human recombinant His6-tagged carbonyl reductase 1 expressed in Escherichia coli BL21(DE3) using menadione as substrate by Michaelis-Menten plot analysis";"Homo sapiens";"2";"4";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2177050";"22982121";"10.1016/j.ejmech.2012.08.023";"2012";"Eur J Med Chem";"56";"145";"154";"";"";"";"";"";""
"CHEMBL2149450";"A";"Cytotoxicity against PMA-stimulated human THP1 cells after 72 hrs by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"THP-1";"";"CHEMBL2146369";"22939695";"10.1016/j.bmcl.2012.07.100";"2012";"Bioorg Med Chem Lett";"22";"6272";"6275";"";"";"";"";"";""
"CHEMBL1614132";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"179";"188";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794399";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling. (Class of assay: confirmatory) ";"";"412";"451";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1046150";"A";"Permeability at pH 6.5 by PAMPA method";"";"33";"33";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1156784";"19947605";"10.1021/jm901421c";"2010";"J Med Chem";"53";"392";"401";"";"";"";"";"";""
"CHEMBL716834";"F";"Percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 11 mg/kg/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL713478";"F";"In vivo screening in M109 syngeneic solid mouse tumor model (i.v.)";"Mus musculus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"M109";"";"CHEMBL1133092";"10669575";"10.1021/jm990498j";"2000";"J Med Chem";"43";"475";"487";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL876078";"F";"Effect on cross resistance of CHO cells resistant to colchicine (CHRC5)";"Cricetulus griseus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL936124";"B";"Inhibition of synthetic amyloid beta-42 fibrillation by ThT fluorescence analysis relative to control";"";"36";"36";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1143831";"17284452";"10.1074/jbc.m608207200";"2007";"J Biol Chem";"282";"10311";"10324";"";"";"";"";"";""
"CHEMBL947537";"B";"Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method";"Saccharomyces cerevisiae";"26";"26";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1150198";"1812211";"10.1021/np50078a006";"1991";"J Nat Prod";"54";"1522";"1530";"";"";"";"";"";""
"CHEMBL4029350";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1250112";"B";"Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy";"Homo sapiens";"4";"4";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1240302";"16408022";"10.1038/nchembio723";"2005";"Nat Chem Biol";"1";"167";"173";"";"";"";"";"";""
"CHEMBL1613808";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ";"Homo sapiens";"7224";"7260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909310";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909316";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909320";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909311";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909313";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL802172";"B";"Maximal binding (nmax) sites to herring sperm DNA. Estimated from Scatchard plots";"Clupeidae";"9";"9";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"55118";"";"";"";"";"CHEMBL1121550";"7452665";"10.1021/jm00185a003";"1980";"J Med Chem";"23";"1166";"1170";"";"";"";"";"";""
"CHEMBL3281963";"P";"Dissociation constant, pKa of the compound";"";"3";"3";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL687002";"F";"In vitro concentration required to induce apoptosis in HL60R cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL628290";"P";"Calculated membrane partition coefficient (Kmemb)";"";"75";"76";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1149124";"15027870";"10.1021/jm0309001";"2004";"J Med Chem";"47";"1783";"1788";"";"";"";"";"";""
"CHEMBL633732";"P";"Partition coefficient in octanol-phosphate buffer at pH 7.4";"";"11";"11";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1123251";"3761325";"10.1021/jm00160a047";"1986";"J Med Chem";"29";"2074";"2079";"";"";"";"";"";""
"CHEMBL3378948";"F";"Antiproliferative activity against human A549 cells by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3351563";"25467291";"10.1016/j.bmc.2014.11.015";"2015";"Bioorg Med Chem";"23";"141";"148";"";"";"";"";"";""
"CHEMBL3232570";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.2 mg/kg, ip administered as qd for 1 to 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1909319";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3214970";"F";"PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ";"";"1095";"1204";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614328";"F";"PUBCHEM_BIOASSAY: Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2585 (qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"";"311";"316";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL747434";"F";"T/C of median tumor volumes when 3 mg/kg/dose of compound was given to BALB/c mice bearing sc M109 on days 1 and 4 (ip) after inoculation (control ~2000 mm**3)";"Mus musculus";"13";"13";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL890793";"F";"Cytotoxicity against ARN8 cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ARN8";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL939585";"F";"Intrinsic cytotoxicity against mouse NIH/3T3 cells overexpressing MDR1 after 72 hrs by MTT assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL1152290";"18954040";"10.1021/jm800403b";"2008";"J Med Chem";"51";"7132";"7143";"";"";"";"";"";""
"CHEMBL1777077";"F";"Cytotoxicity against human KB-C2 cells after 6 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-C2";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL1777078";"F";"Cytotoxicity against human MCF7 cells after 6 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1773024";"21493075";"10.1016/j.bmc.2011.03.055";"2011";"Bioorg Med Chem";"19";"2790";"2796";"";"";"";"";"";""
"CHEMBL1108963";"P";"Octanol-water partition coefficient, log P of the compound";"";"55";"55";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1157036";"20106561";"10.1016/j.ejmech.2009.12.043";"2010";"Eur J Med Chem";"45";"1639";"1647";"";"";"";"";"";""
"CHEMBL2345826";"F";"Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL1286011";"B";"Displacement of DNA-bound ethidium bromide from calf thymus DNA by fluorescence assay";"Bos taurus";"35";"35";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1275381";"20961767";"10.1016/j.bmc.2010.08.025";"2010";"Bioorg Med Chem";"18";"8119";"8133";"";"";"";"";"";""
"CHEMBL1613948";"F";"PUBCHEM_BIOASSAY: Cell-based secondary assay for identifying Hsp90 inhibitors that degrade Hsp90 client protein Her2. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)]";"Homo sapiens";"79";"81";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL865222";"F";"Increase in the level of drug uptake in Dox-resistant K562 cells in presence of cyclosporine over its absence";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL1614425";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"216";"222";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614087";"F";"PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ";"Mus musculus";"51951";"52238";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10090";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL833954";"F";"Cytotoxicity against SW620 colon cancer cell line done for 72 h at 37 degree C with compound in MTS assay";"Homo sapiens";"7";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW-620";"";"CHEMBL1145165";"16078845";"10.1021/jm050144u";"2005";"J Med Chem";"48";"5269";"5278";"";"";"";"";"";""
"CHEMBL1804215";"F";"Anticancer activity against human SF268 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL1614329";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"176";"182";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL662947";"F";"Inhibition of [3H]thymidine incorporation into proliferating L1210 cells.";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122652";"6716401";"10.1021/jm00371a014";"1984";"J Med Chem";"27";"638";"645";"";"";"";"";"";""
"CHEMBL694792";"F";"Antiproliferative activity of compound was tested against melanoma (IgR-37) human tumor cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"IGR-37 cell line";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL1018093";"B";"Inhibition of HIV1 RT";"Human immunodeficiency virus 1";"152";"153";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL1137798";"1710653";"10.1021/np50073a012";"1991";"J Nat Prod";"54";"143";"154";"";"";"";"";"";""
"CHEMBL618619";"F";"Antiproliferative activity of compound was tested against rhabdomyosarcoma (A-204) human tumor cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A204";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL890791";"F";"Cytotoxicity against MCF7 cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL890792";"F";"Cytotoxicity against K562 cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL716675";"F";"Number of mice(with Colon 38 tumors) cured after treatment of 3.9 mg/kg/day dose given as 3 times in a day for 4 days out of 5 mice";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638202";"Colon";"";"";"CHEMBL1136718";"12620081";"10.1021/jm020420u";"2003";"J Med Chem";"46";"1049";"1054";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL755397";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for % increase in life span at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529276";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL890790";"F";"Cytotoxicity against CEM cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL3256434";"F";"In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 2 mg/kg, ip administered on days 1 to 9 relative to control";"Mus musculus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3253042";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1908286";"A";"Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL3256022";"F";"Inhibition of RNA synthesis in mouse L1210 cells";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3285220";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.5 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529272";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3562069";"F";"PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614435";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"86";"93";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737994";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]";"";"15530";"15589";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1176775";"F";"Cytotoxicity against human SF268 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL1176778";"F";"Cytotoxicity against human SF268 cells after 72 hrs by XTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL3285219";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL861415";"F";"Cytotoxicity against doxorubicin-resistant K562 cell line by MTS assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1138154";"16509594";"10.1021/jm050916m";"2006";"J Med Chem";"49";"1792";"1799";"";"";"";"";"";""
"CHEMBL808654";"B";"Inhibitory activity against telomerase at 50 uM concentration (Compound released from RNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3)";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1133811";"11591511";"10.1016/s0960-894x(01)00553-4";"2001";"Bioorg Med Chem Lett";"11";"2727";"2730";"";"";"";"";"";""
"CHEMBL1909133";"B";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614052";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ";"Homo sapiens";"14862";"14887";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909085";"B";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3987361";"Submaxillary gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614053";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-013. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"166";"174";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL691584";"F";"Tested for the cytotoxicity (continuous incubation) against human colon tumor cell lines (HT 29) determined by clonogenic assay.";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL1909205";"B";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965580";"B";"Inhibition of mouse brain MAOB";"Mus musculus";"241";"244";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL2025171";"F";"Induction of adhesion in human MONO-MAC-6 cells at 10'-8 to 10'-6 M after 24 hrs by electrical impedence method relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3057680";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 uM after 10 min";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL1909186";"B";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL860243";"F";"Drug resistance index (ratio of IC50 in drug-resistant cells over drug-sensitive cells)";"";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"K562";"";"CHEMBL1138154";"16509594";"10.1021/jm050916m";"2006";"J Med Chem";"49";"1792";"1799";"";"";"";"";"";""
"CHEMBL2345819";"B";"Displacement of YOYO1 from phage lambda DNA by FID assay";"Enterobacteria phage lambda";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10710";"";"";"";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL987562";"F";"Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL754309";"F";"Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1909318";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909312";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909317";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909308";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909309";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1647778";"F";"Cytotoxicity against human HT-29 cells after 24 hrs by MTS assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL701770";"F";"In vitro cytotoxicity using human epidermoid carcinoma (KB-3-1) cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB 3-1";"";"CHEMBL1129201";"None";"10.1016/0960-894X(96)00457-X";"1996";"Bioorg Med Chem Lett";"6";"2473";"2476";"";"";"";"";"";""
"CHEMBL936125";"B";"Inhibition of synthetic amyloid beta-42 fibrillation by light scattering analysis relative to control";"";"38";"38";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1143831";"17284452";"10.1074/jbc.m608207200";"2007";"J Biol Chem";"282";"10311";"10324";"";"";"";"";"";""
"CHEMBL1046151";"A";"Oral bioavailability in human";"Homo sapiens";"33";"33";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1156784";"19947605";"10.1021/jm901421c";"2010";"J Med Chem";"53";"392";"401";"";"";"";"";"";""
"CHEMBL3057684";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.4 uM in presence of Mg2+";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL1614459";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ";"Drosophila";"88408";"88432";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"7215";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL689647";"F";"In vitro inhibitory concentration against proliferation of HL60 cells";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL1100804";"F";"Cytotoxicity against human KB cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1153791";"19606850";"10.1021/np900109y";"2009";"J Nat Prod";"72";"1447";"1452";"";"";"";"";"";""
"CHEMBL650410";"F";"Compound was tested for antibacterial activity against Bacillus subtilis ATCC E6051";"Bacillus subtilis";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1423";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1697800";"A";"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1614399";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response. (Class of assay: confirmatory) [Related pubchem assays: 914 (Primary screen.), 915 (Primary screen.)]";"Homo sapiens";"102";"106";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL766426";"F";"Compound was tested for effect of glycoside on superoxide production in rat heart sarcosomes";"Rattus norvegicus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL821051";"F";"In vitro antiproliferative activity against Yoshida cell lines";"Rattus norvegicus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"YOSHIDA";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL634454";"A";"Compound was evaluated for the change in Tm of isolated helical DNA in solution.";"";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1123251";"3761325";"10.1021/jm00160a047";"1986";"J Med Chem";"29";"2074";"2079";"";"";"";"";"";""
"CHEMBL861462";"F";"Cytotoxicity against Jurkat T lymphocytes by MTT assay";"Homo sapiens";"3";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Jurkat";"";"CHEMBL1140422";"16366602";"10.1021/jm050902g";"2005";"J Med Chem";"48";"8209";"8219";"";"";"";"";"";""
"CHEMBL913184";"F";"Antiproliferative activity against drug resistant HCT15 cell line expressing MDR1 by Alamar Blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-15";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL914270";"F";"Antiproliferative activity against drug sensitive Messa cell line by Alamar Blue assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1142860";"17286393";"10.1021/jm061348t";"2007";"J Med Chem";"50";"1001";"1006";"";"";"";"";"";""
"CHEMBL3378949";"F";"Antiproliferative activity against human MCF7 cells by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3351563";"25467291";"10.1016/j.bmc.2014.11.015";"2015";"Bioorg Med Chem";"23";"141";"148";"";"";"";"";"";""
"CHEMBL3378950";"F";"Antiproliferative activity against human MDA-MB-231 cells by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3351563";"25467291";"10.1016/j.bmc.2014.11.015";"2015";"Bioorg Med Chem";"23";"141";"148";"";"";"";"";"";""
"CHEMBL1614303";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore). (Class of assay: confirmatory) [Related pubchem assays: 875 ]";"Homo sapiens";"77";"81";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794542";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ";"";"378";"432";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL708939";"F";"In vitro cytotoxicity using murine leukemia L1210 cells from american type culture collection.";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129201";"None";"10.1016/0960-894X(96)00457-X";"1996";"Bioorg Med Chem Lett";"6";"2473";"2476";"";"";"";"";"";""
"CHEMBL3232251";"T";"Mutagenic activity in Salmonella typhimurium TA1537 assessed as mutation frequency at 10'4 times D50 after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"30";"34";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA1537";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL1794510";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) ";"";"414";"466";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL975110";"F";"Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1158125";"17190447";"10.1021/np060273t";"2006";"J Nat Prod";"69";"1711";"1714";"";"";"";"";"";""
"CHEMBL681584";"F";"In vitro antiproliferative activity against Fibroblasts; not determined";"";"2";"2";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL1909193";"B";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909173";"B";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909182";"B";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909107";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638255";"Striatum";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909084";"B";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909088";"B";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909115";"B";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"Escherichia coli";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909126";"B";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909146";"B";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909164";"B";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909110";"B";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Jurkat";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909113";"B";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909094";"B";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"MDCK";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909149";"B";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738132";"F";"PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709]";"Homo sapiens";"20533";"20540";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794483";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623]";"";"114923";"115311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL690451";"F";"Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HMEC";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL1794561";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling. (Class of assay: confirmatory) ";"";"269";"281";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2184160";"B";"Activity of human AKR1A1 expressed in Escherichia coli BL21 assessed per mg protein in presence of 0.2 mM NADPH";"Homo sapiens";"2";"2";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2177050";"22982121";"10.1016/j.ejmech.2012.08.023";"2012";"Eur J Med Chem";"56";"145";"154";"";"";"";"";"";""
"CHEMBL890797";"F";"Cytotoxicity against A549 cells after 72 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL1741321";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909178";"B";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638233";"Cerebellum";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909145";"B";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909159";"B";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1647771";"F";"Cytotoxicity against human MCF7 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1641417";"21094049";"10.1016/j.bmc.2010.10.054";"2011";"Bioorg Med Chem";"19";"603";"612";"";"";"";"";"";""
"CHEMBL707772";"F";"compound was tested in vitro for inhibition activity against a sensitive human breast carcinoma line cells.";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1130103";"9258351";"10.1021/jm970237e";"1997";"J Med Chem";"40";"2452";"2461";"";"";"";"";"";""
"CHEMBL2354301";"F";"PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"1637";"1637";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"RMG-I";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214963";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"1499";"1502";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282188";"B";"Inhibition of Escherichia coli DNA-dependent RNA polymerase assessed as [3H]UMP incorporation into RNA using calf thymus DNA at 0.12 mM by liquid scintillation counting";"Escherichia coli";"3";"3";"BAO_0000223";"protein complex format";"6";"6 - Homologous protein complex subunits assigned";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL681212";"F";"Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 3.1 ug/mL)";"Escherichia coli";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL1121563";"6779008";"10.1021/jm00185a020";"1980";"J Med Chem";"23";"1242";"1244";"";"";"";"";"";""
"CHEMBL871091";"F";"Cytotoxicity against human HeLa3 cell line by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1146888";"16942037";"10.1021/jm060471h";"2006";"J Med Chem";"49";"5626";"5630";"";"";"";"";"";""
"CHEMBL855054";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL3529295";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529294";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL702593";"F";"Cytotoxic activity against L-1210 parental cell line";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210 (1565)";"";"CHEMBL1128855";"None";"10.1016/0960-894X(95)00067-4";"1995";"Bioorg Med Chem Lett";"5";"593";"596";"";"";"";"";"";""
"CHEMBL855052";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL727268";"F";"Antitumor activity against mice baering P388 leukemia (10e6 cells) implanted ip on day 0, after treatment with three ip doses (8 mg/kg) on day 5,9,13 when tumor became systemic.";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122652";"6716401";"10.1021/jm00371a014";"1984";"J Med Chem";"27";"638";"645";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL758084";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for mortality range at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1794375";"B";"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]";"";"83389";"88483";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL939586";"A";"Intrinsic cytotoxicity against wild type mouse NIH/3T3 cells after 72 hrs by MTT assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL1152290";"18954040";"10.1021/jm800403b";"2008";"J Med Chem";"51";"7132";"7143";"";"";"";"";"";""
"CHEMBL1176784";"F";"Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL3254891";"F";"Inhibition of RNA synthesis in mouse L1210 cells compound preincubated for 3 hrs followed by [3H]uridine addition measured after 1 hr by scintillation counting";"Mus musculus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"";"";"";"";"";""
"CHEMBL712028";"F";"compound was tested in vitro for inhibition activity against doxorubicin resistant counterpart of human breast carcinoma line cells.";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL1130103";"9258351";"10.1021/jm970237e";"1997";"J Med Chem";"40";"2452";"2461";"";"";"";"";"";""
"CHEMBL704750";"F";"Inhibitory activity was measured against murine L1210 leukemia cells.";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1131092";"9733483";"10.1021/jm970589l";"1998";"J Med Chem";"41";"3572";"3581";"";"";"";"";"";""
"CHEMBL890798";"A";"Cytotoxicity against mouse NIH 3T3 cells after 72 hrs";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL1146230";"17608396";"10.1021/jm0613572";"2007";"J Med Chem";"50";"3667";"3673";"";"";"";"";"";""
"CHEMBL854754";"F";"Tested for the cytotoxicity(1 hour incubation) against L1210 leukemia cells.";"Mus musculus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL4352935";"F";"Cytostatic activity against human PANC1 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PANC-1";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL814845";"F";"Ratio of DNA relaxation times by topoisomerase in presence of 2 uM of compound (t1/e(+drug) / t 1/e(-drug))";"";"5";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127472";"7932544";"10.1021/jm00045a026";"1994";"J Med Chem";"37";"3191";"3194";"";"";"";"";"";""
"CHEMBL3215038";"F";"PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"605";"605";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215105";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"2629";"2638";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL947536";"B";"Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method";"Bos taurus";"26";"26";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1150198";"1812211";"10.1021/np50078a006";"1991";"J Nat Prod";"54";"1522";"1530";"";"";"";"";"";""
"CHEMBL819955";"F";"In vitro antiproliferative activity against Walker cell line";"Rattus norvegicus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"WALKER";"";"CHEMBL1130292";"None";"10.1016/S0960-894X(97)10152-4";"1997";"Bioorg Med Chem Lett";"7";"3095";"3100";"";"";"";"";"";""
"CHEMBL3214875";"F";"PubChem BioAssay. qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"874";"882";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL725383";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 12(mg/kg)/day, iv; 6/34";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL2025756";"B";"Inhibition of topoisomerase 2 in human DU145 cells assessed as stabilization of enzyme-DNA cleavage complex at 90 nM after 72 hrs by immunoblot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025763";"A";"Drug uptake in human A549 cell nucleus at 1 uM after 4 hrs by confocal microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A549";"Nucleus";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2114780";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ";"Homo sapiens";"58729";"58906";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"SW480";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114715";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay. (Class of assay: confirmatory) ";"";"154";"154";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114796";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ";"Homo sapiens";"8305";"8310";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL841827";"F";"Antitumor activity against P-388 leukemia cell line in BDF1 mice after injecting 8.0 mg/kg ip dose";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124896";"2391681";"10.1021/jm00171a010";"1990";"J Med Chem";"33";"2375";"2379";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL713911";"F";"The compound was evaluated for the growth inhibition of MES-SA uterine tumor cell lines using MTT assay.";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1133378";"10698449";"10.1016/s0960-894x(99)00667-8";"2000";"Bioorg Med Chem Lett";"10";"261";"264";"";"";"";"";"";""
"CHEMBL2076198";"F";"TP_TRANSPORTER: inhibition of DNP-SG uptake in membrane vesicles from GLC4/ADR cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"GLC-4/ADR";"Membrane vesicle";"CHEMBL2074115";"9188796";"10.1016/s0005-2736(97)00003-5";"1997";"Biochim Biophys Acta";"1326";"12";"22";"";"";"";"";"";""
"CHEMBL3285236";"B";"Binding affinity to calf thymus DNA assessed as decrease in absorptivity of visible maxima of compound at 1:1 to 16:1 compound to DNA ratio by UV-visible spectra analysis";"Bos taurus";"4";"4";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"";"";"";"";"";""
"CHEMBL2077538";"F";"TP_TRANSPORTER: uptake in BCRP-expressing oocyte cells";"Xenopus laevis";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"8355";"";"";"Oocyte";"";"CHEMBL2074207";"14645676";"10.1124/mol.64.6.1452";"2003";"Mol Pharmacol";"64";"1452";"1462";"";"";"";"";"";""
"CHEMBL3057681";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.05 uM after 30 min";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL3057682";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at > 0.1 uM after 10 min";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL1794585";"F";"PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ";"";"35474";"35582";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114930";"F";"PubChem BioAssay. qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation. (Class of assay: confirmatory) ";"Homo sapiens";"368";"368";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114775";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ";"";"75093";"75549";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2092592";"F";"HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells";"Plasmodium berghei";"37";"37";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ANKA";"Harvard Malaria Screening";"5821";"";"";"HepG2";"";"CHEMBL2092589";"22586124";"10.1073/pnas.1118370109";"2012";"Proc Natl Acad Sci U S A";"109";"8511";"8516";"";"";"";"";"";""
"CHEMBL2075196";"F";"TP_TRANSPORTER: inhibition of Azidopine photoaffinity labelling (Azidopine: 0.4 uM, Daunorubicin: 400 uM) in membranes from MDR1-expressing LLC-PK1 cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"Membrane";"CHEMBL2073866";"10746169";"10.1248/bpb.22.1355";"1999";"Biol Pharm Bull";"22";"1355";"1359";"";"";"";"";"";""
"CHEMBL2114843";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"68426";"68635";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114853";"F";"PubChem BioAssay. qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"180";"202";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2025748";"B";"Inhibition of HDAC6-mediated tubulin acetylation in human DU145 cells at 500 nM after 4 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL758086";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388/L-PAM for total dose at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3215236";"F";"PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"483";"483";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3378947";"F";"Antiproliferative activity against human H1299 cells by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL3351563";"25467291";"10.1016/j.bmc.2014.11.015";"2015";"Bioorg Med Chem";"23";"141";"148";"";"";"";"";"";""
"CHEMBL3378951";"A";"Antiproliferative activity against human MRC5 cells by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MRC5";"";"CHEMBL3351563";"25467291";"10.1016/j.bmc.2014.11.015";"2015";"Bioorg Med Chem";"23";"141";"148";"";"";"";"";"";""
"CHEMBL729575";"F";"Percentage rate of O2 consumption by liver microsomes and NADPH in the presence compared to the rate in presence of doxorubicin.";"Mus musculus";"9";"10";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"";"Microsomes";"CHEMBL1122183";"7086816";"10.1021/jm00343a004";"1982";"J Med Chem";"25";"18";"24";"";"";"";"";"";""
"CHEMBL1909165";"B";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"";"";"Reticulocytes";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909212";"B";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909125";"B";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909163";"B";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"Cavia porcellus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10141";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2345821";"F";"Cytotoxicity against mouse DA-3 cells assessed as reduction in cell viability at 20 uM after 60 mins by XTT assay";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"DA-3 cell line";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL1909169";"B";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909195";"B";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613992";"F";"PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ";"Homo sapiens";"10316";"10385";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614036";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"96";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909093";"B";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL981345";"F";"Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981347";"F";"Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981348";"F";"Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1794371";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) ";"";"423";"480";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL883253";"F";"Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in B16 mouse melanoma cells using MTS assay.";"Mus musculus";"27";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1133679";"11020285";"10.1021/jm000073t";"2000";"J Med Chem";"43";"3704";"3713";"";"";"";"";"";""
"CHEMBL747977";"F";"Activity of NADH dehydrogenase was determined";"";"4";"4";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1126673";"8421288";"10.1021/jm00053a005";"1993";"J Med Chem";"36";"38";"41";"";"";"";"";"";""
"CHEMBL2149453";"F";"Antileishmanial activity against promastigotes of wild type Leishmania tropica LRC after 72 hrs by MTT assay";"Leishmania tropica";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"LRC";"Scientific Literature";"5666";"";"";"";"";"CHEMBL2146369";"22939695";"10.1016/j.bmcl.2012.07.100";"2012";"Bioorg Med Chem Lett";"22";"6272";"6275";"";"";"";"";"";""
"CHEMBL745296";"F";"Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as treated/ control mean tumor volume on day 30";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1017687";"F";"Cytotoxicity against human HL60 cells after 48 hrs by trypan blue exclusion method";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1154463";"18339455";"10.1016/j.ejmech.2008.01.007";"2008";"Eur J Med Chem";"43";"2386";"2394";"";"";"";"";"";""
"CHEMBL650278";"F";"Compound was tested for its lambda-phage induction activity against Bacillus subtilis in a disk plate assay at concentration of dose of 0.8 ug/mL; Active";"Bacillus subtilis";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1423";"";"";"";"";"CHEMBL1121563";"6779008";"10.1021/jm00185a020";"1980";"J Med Chem";"23";"1242";"1244";"";"";"";"";"";""
"CHEMBL809626";"F";"Compound was tested for antibacterial activity against Staphylococcus aureus WSU-196E";"Staphylococcus aureus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1280";"";"";"";"";"CHEMBL1123433";"3018245";"10.1021/jm00159a024";"1986";"J Med Chem";"29";"1709";"1714";"";"";"";"";"";""
"CHEMBL1613918";"F";"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]";"Homo sapiens";"18608";"18631";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2092594";"F";"HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection";"Plasmodium falciparum";"24";"24";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Dd2";"Harvard Malaria Screening";"5833";"";"";"";"";"CHEMBL2092589";"22586124";"10.1073/pnas.1118370109";"2012";"Proc Natl Acad Sci U S A";"109";"8511";"8516";"";"";"";"";"";""
"CHEMBL2077060";"F";"TP_TRANSPORTER: drug resistance in MRP6-expressing CHO cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"CHO";"";"CHEMBL2074285";"12414644";"None";"2002";"Cancer Res";"62";"6172";"6177";"";"";"";"";"";""
"CHEMBL635477";"P";"Partition coefficient (logD7.4)";"";"61";"66";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL2025281";"B";"Inhibition of HDAC8 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2114895";"F";"PubChem BioAssay. qHTS assay for small molecule activators of the p53 signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"263";"303";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2025753";"B";"Inhibition of topoisomerase 2 in human DU145 cells assessed as stabilization of enzyme-DNA cleavage complex at 90 nM after 30 mins by immunoblot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025735";"F";"Antiproliferative activity against human DU145 cells after 72 hrs by MTS assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL709124";"F";"Antiproliferative activity of compound was tested against mammary carcinoma (MCF-7) human tumor cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL845906";"F";"Resistant Factor against MDR cell lines. Value expressed as ratio of IC50 on the resistant cell and on the corresponding sensitive cells.";"";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"MDR";"";"CHEMBL1129201";"None";"10.1016/0960-894X(96)00457-X";"1996";"Bioorg Med Chem Lett";"6";"2473";"2476";"";"";"";"";"";""
"CHEMBL681209";"F";"Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 1.6 ug/mL)";"Escherichia coli";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL1121563";"6779008";"10.1021/jm00185a020";"1980";"J Med Chem";"23";"1242";"1244";"";"";"";"";"";""
"CHEMBL3215278";"F";"PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ";"";"23091";"23148";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354311";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ";"";"31581";"31649";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214809";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: BLM Helicase Counterscreen for WRN Inhibitors.   (Class of assay: confirmatory) ";"";"505";"505";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215270";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"22759";"22913";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231599";"F";"Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 16 mg/kg, ip on days 5, 9 and 13 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:16.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4495582";"F";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate";"Severe acute respiratory syndrome coronavirus 2";"7218";"8702";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"SARS-CoV-2 Screening Data 2020-21";"2697049";"";"";"";"";"CHEMBL4495564";"None";"10.6019/CHEMBL4495564";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4352937";"F";"Cytostatic activity against human PC3 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4194065";"F";"Cytotoxicity in human HCT16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4190345";"28923382";"10.1016/j.ejmech.2017.09.009";"2017";"Eur J Med Chem";"140";"141";"154";"";"";"";"";"";""
"CHEMBL1613842";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ";"Homo sapiens";"33402";"33647";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL981350";"F";"Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981351";"F";"Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1285392";"B";"Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u";"Candida albicans";"66";"66";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5476";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL819655";"F";"Antiproliferative activity of compound was tested against colon carcinoma (WiDr) human tumor cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1128100";"None";"10.1016/0960-894X(95)00523-3";"1995";"Bioorg Med Chem Lett";"5";"2975";"2980";"";"";"";"";"";""
"CHEMBL815821";"F";"Cytotoxicity against WIDR tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL2025150";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 72 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL4352928";"F";"Cytostatic activity against human A2058 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2058";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352929";"F";"Cytostatic activity against human M24 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3508186";"A";"Plasma clearance of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3137739";"T";"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1030903";"F";"Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 2.9 mg/kg, ip relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"standard_type:DOSE standard_relation:= standard_value:2.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models | Xenograft Oncology Models";"P388 Experimental Leukemia | Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL1804216";"A";"Antiproliferative activity against human MRC5 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MRC5";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL1286008";"B";"Binding affinity to calf thymus DNA assessed as change in melting temperature at drug/DNA ratio 1";"Bos taurus";"1";"1";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1275381";"20961767";"10.1016/j.bmc.2010.08.025";"2010";"Bioorg Med Chem";"18";"8119";"8133";"";"";"";"";"";""
"CHEMBL1794376";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of vitamin D receptor signaling. (Class of assay: confirmatory) ";"";"205";"235";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794382";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ";"";"332";"385";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL690290";"F";"In vitro inhibitory concentration against proliferation of HL60R cells along with 5 (uM) verapamil";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1144989";"12877593";"10.1021/jm030785u";"2003";"J Med Chem";"46";"3546";"3554";"";"";"";"";"";""
"CHEMBL2077081";"F";"TP_TRANSPORTER: ATP hydrolysis in membrane vesicle from BCRP-expressing Sf9 cells";"";"5";"5";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Sf9";"Membrane vesicle";"CHEMBL2074508";"11437380";"10.1006/bbrc.2001.5130";"2001";"Biochem Biophys Res Commun";"285";"111";"117";"";"";"";"";"";""
"CHEMBL3561981";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ";"";"168";"168";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256436";"F";"In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.5 mg/kg, ip administered on days 1 to 9 relative to control";"Mus musculus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL4352926";"F";"Cytostatic activity against human NCI-H1650 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1650";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352932";"F";"Cytostatic activity against human PE/CA-PJ15 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352933";"F";"Cytostatic activity against human PECAPJ41 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352934";"F";"Cytostatic activity against human OVCAR3 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3281266";"F";"Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 3 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3529279";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529278";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529274";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL2078150";"F";"TP_TRANSPORTER: inhibition of Taxol transepithelial transport (basal to apical) in Caco-2 cells";"";"8";"8";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Caco-2";"";"CHEMBL2074126";"11405287";"10.1023/a:1011076217118";"2001";"Pharm Res";"18";"171";"176";"";"";"";"";"";""
"CHEMBL3418660";"F";"Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL3562119";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ";"";"2170";"2186";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256021";"F";"Inhibition of DNA synthesis in mouse L1210 cells";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3285221";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.25 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3256439";"T";"Cardiotoxicity in rat EEG model";"Rattus norvegicus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3256023";"P";"Partition coefficient, log P of the compound";"";"14";"14";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3281262";"F";"Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 1 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL2025148";"F";"Cytostatic activity against human HT-29 cells after 4 days by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3529288";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3562121";"F";"PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"96";"97";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3283127";"A";"Antiproliferative activity against MEF after 72 hrs";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"MEF";"";"CHEMBL3272277";"1271420";"10.1021/jm00227a033";"1976";"J Med Chem";"19";"733";"734";"";"";"";"";"";""
"CHEMBL1794471";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) ";"";"241";"270";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL758537";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for tumor free survivors at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL755396";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for change in body weight at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1804214";"F";"Anticancer activity against human NCI-H460 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1800004";"21599000";"10.1021/jm200046z";"2011";"J Med Chem";"54";"4446";"4461";"";"";"";"";"";""
"CHEMBL989024";"B";"Binding affinity to calf thymus DNA in BPES buffer assessed as binding constant K/10'5 by fluorescence titration";"Bos taurus";"2";"2";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1140110";"18788722";"10.1021/jm800826y";"2008";"J Med Chem";"51";"5909";"5911";"";"";"";"";"";""
"CHEMBL711758";"F";"The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) expressing LacZ (beta-galactosidase).";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-361";"";"CHEMBL1132269";"10395490";"10.1021/jm980696v";"1999";"J Med Chem";"42";"2485";"2489";"";"";"";"";"";""
"CHEMBL725381";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 11 mg/kg/day, iv; 0/37";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL3283126";"F";"Cytotoxicity against human HeLa cells assessed as cloning efficiency after 8 hrs";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3272277";"1271420";"10.1021/jm00227a033";"1976";"J Med Chem";"19";"733";"734";"";"";"";"";"";""
"CHEMBL865225";"F";"Cytotoxicity against K562 cells by MTS";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1149383";"16451059";"10.1021/jm050800q";"2006";"J Med Chem";"49";"932";"941";"";"";"";"";"";""
"CHEMBL3057683";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 to 1 uM";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL3281264";"F";"Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 5 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3282190";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 6.2 by stop-flow technique in presence of 21 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL3562130";"F";"PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282193";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 201 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL3231220";"F";"Inhibition of RNA synthesis in mouse L1210 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3227939";"423182";"10.1021/jm00187a010";"1979";"J Med Chem";"22";"40";"44";"";"";"";"";"";""
"CHEMBL711760";"F";"The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of CPG2 prodrug";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-361";"";"CHEMBL1132269";"10395490";"10.1021/jm980696v";"1999";"J Med Chem";"42";"2485";"2489";"";"";"";"";"";""
"CHEMBL722418";"F";"In vivo antitumor activity against subcutaneous Colon 38 tumors in mice determined as delay in growth after 3.9 mg/kg/day dose given as 3 times in a day for 4 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1136718";"12620081";"10.1021/jm020420u";"2003";"J Med Chem";"46";"1049";"1054";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL692226";"F";"Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 24 hour";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1126488";"None";"10.1016/S0960-894X(00)80285-1";"1993";"Bioorg Med Chem Lett";"3";"1051";"1054";"";"";"";"";"";""
"CHEMBL4352975";"T";"Toxicity in SCID mouse xenografted with human HT-29 cells assessed as animal death at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured upto 23 days post inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL758384";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for mortality range at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2025743";"B";"Inhibition of HDAC in human DU145 cells assessed as histone H4 acetylation after 24 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2077586";"F";"TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.05 uM) in membrane vesicle from MRP1-expressing HeLa cells";"";"4";"4";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HeLa";"Membrane vesicle";"CHEMBL2074383";"8621644";"10.1074/jbc.271.16.9683";"1996";"J Biol Chem";"271";"9683";"9689";"";"";"";"";"";""
"CHEMBL2026062";"F";"Antitumor activity against mouse C26 cells allografted in Balb/C mouse assessed as tumor growth inhibition";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"C26";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL821429";"B";"Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 20 uM concentration";"";"3";"3";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127472";"7932544";"10.1021/jm00045a026";"1994";"J Med Chem";"37";"3191";"3194";"";"";"";"";"";""
"CHEMBL5113655";"B";"Inhibition of HDAC1 (unknown origin)";"Homo sapiens";"9";"9";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5113372";"33143937";"10.1016/j.ejmech.2020.112844";"2021";"Eur J Med Chem";"209";"112844";"112844";"";"";"";"";"";""
"CHEMBL5113657";"B";"Inhibition of HDAC6 (unknown origin)";"Homo sapiens";"12";"12";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5113372";"33143937";"10.1016/j.ejmech.2020.112844";"2021";"Eur J Med Chem";"209";"112844";"112844";"";"";"";"";"";""
"CHEMBL636076";"P";"Tested for the partition coefficient between water and n-octanol.";"";"13";"13";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1124930";"2296017";"10.1021/jm00163a028";"1990";"J Med Chem";"33";"166";"171";"";"";"";"";"";""
"CHEMBL4352938";"A";"Cytostatic activity against human MRC5 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MRC5";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3232247";"A";"Toxicity in Salmonella typhimurium TA100 assessed as growth inhibition after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA100";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL3232250";"T";"Mutagenic activity in Salmonella typhimurium TA100 assessed as mutation frequency at 10'4 times D50 after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA100";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL3252988";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, po qd administered from day 1 to day 9 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244343";"490537";"10.1021/jm00194a007";"1979";"J Med Chem";"22";"922";"926";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4352988";"F";"Antitumor activity against human HT-29 cells xenografted in NSG mouse assessed as tumor growth inhibition by measuring decrease in tumor growth at 1 mg/kg, iv administered once per week for 7 times starting from 5 days post inoculation measured at day 50 post inoculation";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL3252982";"T";"Cardiotoxicity in rat assessed as minimum cumulative cardiotoxic dose by Zbinden test";"Rattus norvegicus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3562026";"F";"PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ";"";"180";"181";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562064";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ";"";"1996";"2013";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354254";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ";"";"153871";"156311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284958";"F";"Inhibition of RNA synthesis in mouse L1210 cells preincubated for 3 hrs followed by [3H]-uridine addition measured after 1 hr by scintillation spectrometric analysis";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"";"";"";"";"";""
"CHEMBL2076854";"F";"TP_TRANSPORTER: transepithelial transport (apical to basal) of Daunorubicin (Daunomycin) at a concentration of 200 nM in MDR1-expressing LLC-PK1 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074016";"11785684";"10.1023/a:1013358126640";"2001";"Pharm Res";"18";"1660";"1668";"";"";"";"";"";""
"CHEMBL3281263";"F";"Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 3 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3215220";"F";"PubChem BioAssay. Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands.   (Class of assay: confirmatory) ";"";"272";"272";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137733";"T";"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137728";"T";"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137724";"T";"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3256437";"F";"In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.25 mg/kg, ip administered on days 1 to 9 relative to control";"Mus musculus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL2077476";"F";"TP_TRANSPORTER: efflux in Mrp1-expressing HEK293 cells";"";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"";"CHEMBL2073844";"9281595";"10.1124/mol.52.3.344";"1997";"Mol Pharmacol";"52";"344";"353";"";"";"";"";"";""
"CHEMBL655021";"F";"Effect on cross resistance of CCRF-CEM cells resistant to vincristine.";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL3137722";"T";"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2149452";"F";"Antileishmanial activity against promastigotes of multidrug-resistant Leishmania tropica after 72 hrs by MTT assay";"Leishmania tropica";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5666";"";"";"";"";"CHEMBL2146369";"22939695";"10.1016/j.bmcl.2012.07.100";"2012";"Bioorg Med Chem Lett";"22";"6272";"6275";"";"";"";"";"";""
"CHEMBL2328701";"F";"Cytotoxicity against mouse L5178Y cells after 24 hrs by MTT assay";"Mus musculus";"1";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL2321804";"23199479";"10.1016/j.bmc.2012.10.041";"2013";"Bioorg Med Chem";"21";"166";"177";"";"";"";"";"";""
"CHEMBL3137723";"T";"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137734";"T";"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562027";"F";"PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"232";"232";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562123";"F";"PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"228";"229";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282191";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 1 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL5118135";"T";"Cytotoxicity against human MCF-10A cells assessed as growth inhibition at 0.5 uM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF-10A";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL3562033";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4352925";"F";"Cytostatic activity against human A549 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3214946";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Confirmatory Assay for Cherry-picked Compounds..   (Class of assay: confirmatory) ";"";"502";"502";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5118134";"T";"Cytotoxicity against human MCF-10A cells assessed as growth inhibition at 0.25 uM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF-10A";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL2077407";"F";"TP_TRANSPORTER: increase in brain concentration in mdr1a/1b(-/-) mouse";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"5";"5 - Multiple direct protein targets may be assigned";"mdr1a/1b(-/-)";"TP-search Transporter Database";"10090";"CHEMBL3638188";"Brain";"";"";"CHEMBL2074016";"11785684";"10.1023/a:1013358126640";"2001";"Pharm Res";"18";"1660";"1668";"";"";"";"";"";""
"CHEMBL3282668";"B";"Inhibition of Escherichia coli RNA polymerase assessed as reduction in RNA transcription at compound/DNA molar ratio of 1";"Escherichia coli";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL3272174";"926111";"10.1021/jm00219a002";"1977";"J Med Chem";"20";"1117";"1122";"";"";"";"";"";""
"CHEMBL2025737";"F";"Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025759";"A";"Drug uptake in human DU145 cell nucleus at 1 uM after 4 hrs by confocal microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"Nucleus";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL3231212";"B";"Binding affinity to calf thymus DNA assessed as change in melting temperature";"Bos taurus";"3";"3";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL3231308";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as optimal dose";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227963";"423191";"10.1021/jm00188a001";"1979";"J Med Chem";"22";"121";"123";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562124";"F";"PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"231";"231";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529292";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529291";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4352936";"F";"Cytostatic activity against human DU145 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL2184164";"B";"Activity of human carbonyl reductase 1";"Homo sapiens";"2";"4";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2177050";"22982121";"10.1016/j.ejmech.2012.08.023";"2012";"Eur J Med Chem";"56";"145";"154";"";"";"";"";"";""
"CHEMBL4303092";"F";"Overall antiviral activity against SARS-CoV-2 (isolate France/IDF0372/2020) in the Vero E6 cell line at 48 h based on three assays 1) detection of viral RNA by qRT-PCR (targeting the N-gene), 2) plaque assay using lysate 3 days after addition of compound by crystal violet staining 3) Cell viability (cytotoxicity) measuring percentage viable Vero E6 cells 48 h after compound addition by AlamarBlue assay.";"Chlorocebus sabaeus";"59";"59";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078380";"F";"TP_TRANSPORTER: efflux in GLC4/ADR cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"GLC-4/ADR";"";"CHEMBL2074422";"7945406";"10.1016/0006-2952(94)90149-x";"1994";"Biochem Pharmacol";"48";"1129";"1136";"";"";"";"";"";""
"CHEMBL2025153";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 72 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3231683";"F";"Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 1 mg/kg, ip on day 5 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3885882";"F";"In vitro activity on S. mansoni schistosomula at 50 uM";"Schistosoma mansoni";"654";"247666";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Puerto Rican";"DrugMatrix";"6183";"";"";"";"";"CHEMBL3885881";"None";"10.6019/CHEMBL3885881";"None";"None";"None";"None";"None";"standard_type:AGE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:GENDER standard_relation:None standard_value:None standard_units:None comments:None | standard_type:REGIMEN standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4194063";"F";"Cytotoxicity in human RD cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL4190345";"28923382";"10.1016/j.ejmech.2017.09.009";"2017";"Eur J Med Chem";"140";"141";"154";"";"";"";"";"";""
"CHEMBL3231688";"T";"Toxicity in CDF1 mouse allografted with mouse B16 cells at 16 mg/kg, ip on day 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:16.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL5118115";"F";"Growth inhibition of human MDA-MB-231 cells at 1 uM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL2025151";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 24 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2184165";"B";"Ratio of Vmax to Km for human aldo-keto reductase 1A1";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2177050";"22982121";"10.1016/j.ejmech.2012.08.023";"2012";"Eur J Med Chem";"56";"145";"154";"";"";"";"";"";""
"CHEMBL4352917";"F";"Cytostatic activity against human MCF7 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3508188";"A";"Plasma clearance ratio of 13-dihydrometabolite of daunorubicin to daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3284954";"B";"Binding affinity to calf thymus DNA assessed as increase in melting temperature at 2 x 10'-5 M by UV spectrophotometric analysis";"Bos taurus";"1";"1";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"";"";"";"";"";""
"CHEMBL3256156";"B";"Binding affinity to calf thymus DNA assessed as change in melting temperature";"Bos taurus";"18";"18";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3284961";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as change in survival time at 4 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562136";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ";"";"1968";"1982";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256158";"F";"Inhibition of RNA synthesis in mouse L1210 cells";"Mus musculus";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3231691";"T";"Toxicity in CDF1 mouse allografted with mouse P388 cells assessed as survival at 2 to 32 mg/kg, ip on days 5, 9 and 13";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:None standard_value:None standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL4352918";"F";"Cytostatic activity against human MDA-MB-231 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352923";"F";"Cytostatic activity against mouse CT26.WT cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CT26.WT";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352930";"F";"Cytostatic activity against human WM983B cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3231598";"F";"Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 32 mg/kg, ip on days 5, 9 and 13 relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:32.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3232568";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, ip administered as qd for 1 to 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3231203";"T";"Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertants by Ames test";"Salmonella enterica subsp. enterica serovar Typhimurium";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL5053580";"A";"Cytotoxicity against Wistar rat neonatal ventricular cardiomyocytes at 1.2 uM by LDH assay";"Rattus norvegicus";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"Neonatal ventricular cardiomyocytes";"";"CHEMBL5053483";"33750129";"10.1021/acs.jmedchem.0c02157";"2021";"J Med Chem";"64";"3997";"4019";"";"";"";"";"";""
"CHEMBL3232246";"A";"Toxicity in Salmonella typhimurium TA98 assessed as growth inhibition after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL5118124";"F";"Growth inhibition of mouse 4T1 cells at 0.25 uM";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL3231205";"T";"Genotoxicity in Salmonella typhimurium 908 assessed as number of revertants by Ames test";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"908";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL1030896";"F";"Cytotoxicity against human HeLa cells assessed as colony formation at 12.5 ng/ml relative to control";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1151653";"3861771";"10.1021/np50039a011";"1985";"J Nat Prod";"48";"435";"439";"";"";"";"";"";""
"CHEMBL2025147";"F";"Cytostatic activity against human LNCAP cells after 4 days by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LNCaP";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2025158";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 48 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL4352931";"F";"Cytostatic activity against mouse B16 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL2354221";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ";"";"172535";"175189";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282195";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 21 mM Na+ relative to pH 6.2";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL3231195";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 4 mg/kg, ip administered as single dose for every 4 days up to 13 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2354211";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ";"";"35070";"35135";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4399806";"F";"Antiproliferative activity against human RD cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL4396939";"31431363";"10.1016/j.bmcl.2019.08.021";"2019";"Bioorg Med Chem Lett";"29";"126617";"126617";"";"";"";"";"";""
"CHEMBL4352972";"T";"Toxicity in SCID mouse xenografted with human HT-29 cells assessed as body weight loss at 1 mg/kg, ip administered once a week (on day 13 and 20) starting from 13 days post inoculation measured upto 23 days post inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL2025161";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-9 to 10'-6 M after 48 hrs by cell counting method relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2076689";"F";"TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing LLC-PK1 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2073866";"10746169";"10.1248/bpb.22.1355";"1999";"Biol Pharm Bull";"22";"1355";"1359";"";"";"";"";"";""
"CHEMBL2025747";"B";"Inhibition of HDAC6-mediated tubulin acetylation in human DU145 cells at 90 nM after 4 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL3418664";"F";"Cytotoxicity against human K562 cells expressing Bcr-Abl assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL3418665";"F";"Induction of apoptosis in human K562 cells expressing Bcr-Abl after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL2025764";"A";"Drug uptake in human A549 cell perinuclear region at 1 uM after 4 hrs by confocal microscopic analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025154";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 24 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2345812";"A";"Cellular uptake in mouse DA-3 cell lysosome at 10 uM after 30 mins by LysoTracker green staining-based confocal microscopic analysis relative to control";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"DA-3";"Lysosome";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL2345824";"F";"Cytotoxicity against human ES2 cells after 24 hrs by XTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ES2";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL705344";"F";"In vitro cytotoxic activity was evaluated using the KB-3-1 resistant to adriamycin (ADR) subline KB-A1";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL4399804";"F";"Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4396939";"31431363";"10.1016/j.bmcl.2019.08.021";"2019";"Bioorg Med Chem Lett";"29";"126617";"126617";"";"";"";"";"";""
"CHEMBL5153621";"F";"Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by alamar blue assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL5150060";"36449385";"10.1021/acs.jmedchem.2c01132";"2022";"J Med Chem";"65";"16313";"16337";"";"";"";"";"";""
"CHEMBL3214810";"F";"PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Fischer Rat Thyroid (FRT) Cells. Measured in Cell-Based System Using Plate Reader - 7017-02_Other_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"144";"144";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078574";"F";"TP_TRANSPORTER: drug resistance in MRP1-expressing PEAKSTABEL cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"PEAKSTABLE";"";"CHEMBL2074335";"12657726";"None";"2003";"Mol Cancer Ther";"2";"307";"316";"";"";"";"";"";""
"CHEMBL3529283";"A";"Ratio of intestine AUC in po dosed mdr1 knock out mouse to intestine AUC in po dosed wild type mouse";"Mus musculus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638176";"Intestine";"";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4352921";"F";"Cytostatic activity against human HT-29 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL3885883";"F";"In vitro activity on S. mansoni schistosomula at 10 uM";"Schistosoma mansoni";"132";"16436";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Puerto Rican";"DrugMatrix";"6183";"";"";"";"";"CHEMBL3885881";"None";"10.6019/CHEMBL3885881";"None";"None";"None";"None";"None";"standard_type:AGE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:GENDER standard_relation:None standard_value:None standard_units:None comments:None | standard_type:REGIMEN standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2354209";"F";"PubChem BioAssay. S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"33";"33";"BAO_0000217";"biochemical format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2213775";"B";"Binding affinity to calf thymus DNA assessed as binding constant by spectrofluorimetry based McGhee von Hippel method";"Bos taurus";"5";"5";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL2203053";"23122936";"10.1016/j.bmc.2012.09.068";"2012";"Bioorg Med Chem";"20";"7139";"7148";"";"";"";"";"";""
"CHEMBL4303805";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"Homo sapiens";"5616";"5632";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"Caco-2";"";"CHEMBL4303101";"None";"10.21203/rs.3.rs-23951/v1";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231219";"F";"Inhibition of DNA synthesis in mouse L1210 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3227939";"423182";"10.1021/jm00187a010";"1979";"J Med Chem";"22";"40";"44";"";"";"";"";"";""
"CHEMBL3232181";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as average survival time at 2.9 mg/kg, ip relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227963";"423191";"10.1021/jm00188a001";"1979";"J Med Chem";"22";"121";"123";"standard_type:DOSE standard_relation:= standard_value:2.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4352927";"F";"Cytostatic activity against human NCI-H1975 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1975";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL5118125";"F";"Growth inhibition of mouse 4T1 cells at 0.5 uM";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL2184166";"B";"Ratio of Vmax to Km for human carbonyl reductase 1";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2177050";"22982121";"10.1016/j.ejmech.2012.08.023";"2012";"Eur J Med Chem";"56";"145";"154";"";"";"";"";"";""
"CHEMBL3285223";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.06 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL5113669";"F";"Cytotoxicity against human DU-145 cells assessed as cell growth inhibition";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL5113372";"33143937";"10.1016/j.ejmech.2020.112844";"2021";"Eur J Med Chem";"209";"112844";"112844";"";"";"";"";"";""
"CHEMBL3057685";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 uM after 1 hr";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL3284962";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4420581";"F";"Ratio of cytotoxic IC50 for human THP1 (+/+) cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"THP-1";"";"CHEMBL4420068";"None";"None";"2018";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4352919";"F";"Cytostatic activity against mouse 4T1 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL719883";"F";"Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 12(mg/kg)/day, sc";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL756544";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for change in body weight at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3258997";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.20 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4480802";"F";"Cytotoxicity against mouse 4T1 cells after 72 hrs by MTT assay";"Mus musculus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL4480386";"30654237";"10.1016/j.ejmech.2019.01.001";"2019";"Eur J Med Chem";"165";"18";"30";"";"";"";"";"";""
"CHEMBL4480805";"A";"Cytotoxicity against BHK21 cells after 72 hrs by MTT assay";"Mesocricetus auratus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4480386";"30654237";"10.1016/j.ejmech.2019.01.001";"2019";"Eur J Med Chem";"165";"18";"30";"";"";"";"";"";""
"CHEMBL4410669";"B";"Binding affinity to Tetrahymena thermophila telomeric 7 G-quadruplex DNA assessed as binding constant Kb2 in presence of 10 mM KCl by fluorescence spectroscopy";"Tetrahymena thermophila";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5911";"";"";"";"";"CHEMBL4406898";"31685331";"10.1016/j.bmc.2019.115131";"2019";"Bioorg Med Chem";"27";"115131";"115131";"";"";"";"";"";""
"CHEMBL4303819";"F";"Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs";"Chlorocebus sabaeus";"1518";"1520";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303097";"None";"10.1101/2020.04.03.023846";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078553";"F";"TP_TRANSPORTER: ATPase assay in membrane vesicle from BCRP-expressing Lactococcus lactis cells";"Lactococcus lactis";"6";"6";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"NZ9000";"TP-search Transporter Database";"1358";"";"";"";"Membrane vesicle";"CHEMBL2074167";"12668685";"10.1074/jbc.m301358200";"2003";"J Biol Chem";"278";"20645";"20651";"";"";"";"";"";""
"CHEMBL3283130";"F";"Antitumor activity against mouse Sarcoma 180 cells allografted in mouse assessed as average survival time at 2 mg/kg, ip on day 1 post challenge relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Sarcoma-180";"";"CHEMBL3272277";"1271420";"10.1021/jm00227a033";"1976";"J Med Chem";"19";"733";"734";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Sarcoma Oncology Models | Sarcoma Oncology Models";"Neoplasms | Sarcoma | Sarcoma 180";"";""
"CHEMBL3367814";"T";"Genotoxicity in Salmonella typhimurium TA102 at 3 ug/plate assessed as number of revertants per plate (Rvb = 301 +/- 5.2 no unit)";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA102";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3352176";"24907144";"10.1016/j.bmcl.2014.05.017";"2014";"Bioorg Med Chem Lett";"24";"3084";"3087";"";"";"";"";"";""
"CHEMBL2025157";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 24 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3420018";"A";"Genotoxicity in DNA (unknown origin) incubated for 24 hrs in dark condition by methyl green displacement assay";"Not specified";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3414541";"25791675";"10.1016/j.ejmech.2015.03.011";"2015";"Eur J Med Chem";"95";"16";"28";"";"";"";"";"";""
"CHEMBL3256440";"T";"Cardiotoxicity in rat EEG model relative to adriamycin";"Rattus norvegicus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3231681";"F";"Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 4 mg/kg, ip on day 5 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3418662";"F";"Cytotoxicity against human HL60R cells expressing p-glycoprotein assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60R";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL2075276";"F";"TP_TRANSPORTER: RNase protection assay in vitro, rat hepatoma H-4-II-E cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"H-4-II-E";"";"CHEMBL2073882";"9624121";"10.1074/jbc.273.25.15387";"1998";"J Biol Chem";"273";"15387";"15394";"";"";"";"";"";""
"CHEMBL4651403";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"4309";"8710";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"IMI-CARE SARS-CoV-2 Data";"60711";"";"";"Vero C1008";"";"CHEMBL4651402";"None";"10.6019/CHEMBL4651402";"2021";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5118114";"F";"Growth inhibition of human MDA-MB-231 cells at 0.25 uM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL3232185";"T";"Toxicity in mouse allografted with mouse P388 cells at 2.9 mg/kg, ip";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227963";"423191";"10.1021/jm00188a001";"1979";"J Med Chem";"22";"121";"123";"standard_type:DOSE standard_relation:= standard_value:2.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL5118126";"F";"Growth inhibition of mouse 4T1 cells at 1 uM";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL4352982";"F";"Antitumor activity against human HT-29 cells xenografted in SCID mouse assessed as decrease in number of Ki-67 positive cells measured as proliferation index at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured at day 23 post inoculation by KI-67-staining based light microscopic analysis (Rvb = 100%)";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL4817009";"F";"Antiproliferative activity against human MCF7/ADR cells incubated for 48 hrs by CCK-8 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL4813991";"33725657";"10.1016/j.ejmech.2021.113336";"2021";"Eur J Med Chem";"216";"113336";"113336";"";"";"";"";"";""
"CHEMBL5053581";"F";"Antiproliferative activity against human HL-60 cells after 72 hrs by XTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL5053483";"33750129";"10.1021/acs.jmedchem.0c02157";"2021";"J Med Chem";"64";"3997";"4019";"";"";"";"";"";""
"CHEMBL4352943";"A";"Drug uptake in nucleus of human HT-29 cells assessed as increase in fluorescence at 50 uM after 90 mins by fluorescence based confocal microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000220";"subcellular format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HT-29";"Nucleus";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4352971";"F";"Antitumor activity against human HT-29 cells xenografted in SCID mouse assessed as tumor growth inhibition by measuring decrease in tumor weight at 1 mg/kg, ip administered once a week (on day 13 and 20) starting from 13 days post inoculation measured at day 23 post inoculation relative to control";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models | Xenograft Oncology Models";"Neoplasms | Xenograft Models of Anti-Tumor Assays";"";""
"CHEMBL4817018";"B";"Inhibition of P-glycoprotein in human MCF7/ADR cells assessed as reversal fold by measuring reduction in daunorubicin IC50 at 5 uM incubated for 48 hrs by CCK-8 assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL4813991";"33725657";"10.1016/j.ejmech.2021.113336";"2021";"Eur J Med Chem";"216";"113336";"113336";"";"";"";"";"";""
"CHEMBL5113668";"B";"Inhibition of HDAC8 (unknown origin)";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5113372";"33143937";"10.1016/j.ejmech.2020.112844";"2021";"Eur J Med Chem";"209";"112844";"112844";"";"";"";"";"";""
"CHEMBL5118116";"F";"Growth inhibition of human MDA-MB-231 cells at 4 uM";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL5113490";"35830778";"10.1016/j.bmc.2022.116912";"2022";"Bioorg Med Chem";"70";"116912";"116912";"";"";"";"";"";""
"CHEMBL756205";"F";"Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for median day of death at an optimal dose of 1 mg/kg/injection";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125740";"1992140";"10.1021/jm00105a007";"1991";"J Med Chem";"34";"38";"46";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4410668";"B";"Binding affinity to Tetrahymena thermophila telomeric 7 G-quadruplex DNA assessed as binding constant Kb1 in presence of 10 mM KCl by fluorescence spectroscopy";"Tetrahymena thermophila";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5911";"";"";"";"";"CHEMBL4406898";"31685331";"10.1016/j.bmc.2019.115131";"2019";"Bioorg Med Chem";"27";"115131";"115131";"";"";"";"";"";""
"CHEMBL2076251";"F";"TP_TRANSPORTER: ATP hydrolysis in membrane fraction from High Five (BTI-TN5B1-4) cells";"";"12";"12";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"BTI-TN-5B1-4";"Membrane fraction";"CHEMBL2074016";"11785684";"10.1023/a:1013358126640";"2001";"Pharm Res";"18";"1660";"1668";"";"";"";"";"";""
"CHEMBL2076871";"F";"TP_TRANSPORTER: uptake (apical to cell) in OCT2-expressing NIH3T3 cells";"";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"NIH3T3";"";"CHEMBL2074124";"10220855";"10.1093/toxsci/47.2.181";"1999";"Toxicol Sci";"47";"181";"186";"";"";"";"";"";""
"CHEMBL2114842";"F";"PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"512";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL850179";"F";"NADH oxidation by the compound was determined";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1126673";"8421288";"10.1021/jm00053a005";"1993";"J Med Chem";"36";"38";"41";"";"";"";"";"";""
"CHEMBL3561991";"F";"PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ";"";"181";"182";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1176779";"A";"Cytotoxicity against human Detroit 551 cells after 72 hrs by XTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Detroit 551";"";"CHEMBL1177675";"20591678";"10.1016/j.bmc.2010.05.062";"2010";"Bioorg Med Chem";"18";"5172";"5182";"";"";"";"";"";""
"CHEMBL3281268";"A";"Cellular uptake in mouse L1210 cells assessed per 10'6 cells at 3 uM up to 120 mins";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3508166";"A";"Terminal half-life of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3562115";"F";"PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ";"";"138";"139";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232576";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 8 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529289";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529285";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL719311";"F";"Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 12(mg/kg)/day, iv";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL3562144";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214953";"F";"PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ";"";"20285";"20311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2025751";"B";"Inhibition of HDAC in human DU145 cells assessed as upregulation of p21 expression at IC50 concentration after 4 hrs by Western blot analysis relative to control";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025736";"F";"Antiproliferative activity against human SKMES1 cells after 72 hrs by MTS assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-MES-1";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL3215046";"F";"PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ";"";"9563";"9569";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4480804";"F";"Selectivity index, ratio of IC50 for mouse CT26.WT cells to IC50 for mouse 4T1 cells";"Mus musculus";"35";"35";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4480386";"30654237";"10.1016/j.ejmech.2019.01.001";"2019";"Eur J Med Chem";"165";"18";"30";"";"";"";"";"";""
"CHEMBL3258996";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.39 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:0.39 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4813813";"B";"Inhibition of acid-mediated aggregation of TTR V30M mutant (unknown origin) expressed in Escherichia coli pretreated for 30 mins at pH 7 followed by protein dilution in acetate buffer and further incubated for 96 hrs at pH 4.6 by thioflavin-T fluorescence assay";"Homo sapiens";"45";"45";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4811317";"34225167";"10.1016/j.bmc.2021.116292";"2021";"Bioorg Med Chem";"44";"116292";"116292";"";"";"";"";"";""
"CHEMBL725380";"F";"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 10 mg/kg/day, sc; 0/58";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1121551";"7452666";"10.1021/jm00185a004";"1980";"J Med Chem";"23";"1171";"1174";"";"";"";"";"";""
"CHEMBL3282198";"P";"Retardation factor of the compound in 10% methanol-chloroform by TLC";"";"2";"2";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL2078561";"F";"TP_TRANSPORTER: inhibition of Vinblastine transepithelial transport (basal to apical) in MRP2-expressing MDCK cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2073914";"12134946";"10.1023/a:1016192413308";"2002";"Pharm Res";"19";"773";"779";"";"";"";"";"";""
"CHEMBL3232575";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 16 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:16.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3231214";"F";"Inhibition of RNA synthesis in mouse L1210 cells";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL2025745";"B";"Inhibition of HDAC in human DU145 cells assessed as histone H3 hyperacetylation at 0.1 to 0.5 uM after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025149";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 48 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL2025155";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 48 hrs by cell counting method";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3529293";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL705281";"F";"Cytotoxicity against MCF-7 tumor cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1132544";"10602713";"10.1021/jm9910472";"1999";"J Med Chem";"42";"5277";"5283";"";"";"";"";"";""
"CHEMBL4014482";"F";"Growth inhibition of human MCF7/ADR cells after 48 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL4014272";"28246041";"10.1016/j.ejmech.2017.02.022";"2017";"Eur J Med Chem";"130";"154";"170";"";"";"";"";"";""
"CHEMBL3283128";"F";"Inhibition of Murine sarcoma virus (Moloney) foci formation in MEF after 72 hrs";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"MEF";"";"CHEMBL3272277";"1271420";"10.1021/jm00227a033";"1976";"J Med Chem";"19";"733";"734";"";"";"";"";"";""
"CHEMBL3801376";"A";"Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by Alamar Blue assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL3797085";"26937828";"10.1021/acs.jmedchem.5b01478";"2016";"J Med Chem";"59";"2423";"2435";"";"";"";"";"";""
"CHEMBL2025143";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-7 M after 24 hrs by cell counting method relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3256157";"F";"Antitumor activity against mouse P388 cells allografted in CDF/BDF mouse assessed as survival time at 0.78 mg/kg, ip administered as qd for 1 to 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3281269";"U";"Ratio of inhibition of [3H]-thymidine incorporation into DNA in mouse L1210 cells to cellular uptake in mouse L1210 cells";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL4303810";"F";"Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)";"Homo sapiens";"1629";"1637";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"HRCE";"";"CHEMBL4303122";"None";"10.1101/2020.04.21.054387";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215017";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"26950";"27095";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL745295";"F";"Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as treated/ control ( 1000 mm**3) median tumor volume on day 30";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4513082";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"7218";"17404";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4495565";"None";"10.6019/CHEMBL4495565";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3259443";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 8 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3259444";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 4 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3282192";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 21 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL3282196";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 201 mM Na+ relative to 1 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL873095";"F";"In vitro cytotoxic activity was evaluated using the human epidermoid carcinoma cell line KB-3-1";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB 3-1";"";"CHEMBL1134999";"12443763";"10.1016/s0960-894x(02)00823-5";"2002";"Bioorg Med Chem Lett";"12";"3505";"3507";"";"";"";"";"";""
"CHEMBL4352922";"F";"Cytostatic activity against human WiDr cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL2025172";"F";"Induction of adhesion in human MONO-MAC-6 cells at 10'-7 M after 1.5 hrs by electrical impedence method relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3285234";"B";"Binding affinity to calf thymus DNA assessed as bathochromatic shift at 1:1 to 16:1 compound to DNA ratio by UV-visible spectra analysis";"Bos taurus";"4";"4";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"";"";"";"";"";""
"CHEMBL3256435";"F";"In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 1 mg/kg, ip administered on days 1 to 9 relative to control";"Mus musculus";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3281265";"F";"Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 1 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3281267";"F";"Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 5 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272341";"1271407";"10.1021/jm00227a015";"1976";"J Med Chem";"19";"651";"654";"";"";"";"";"";""
"CHEMBL3137732";"T";"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137726";"T";"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2345825";"F";"Cytotoxicity against mouse DA-3 cells after 24 hrs by XTT assay";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"DA-3 cell line";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL3232249";"T";"Mutagenic activity in Salmonella typhimurium TA98 assessed as mutation frequency at 10'4 times D50 after 1 hr";"Salmonella enterica subsp. enterica serovar Typhimurium";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227953";"370390";"10.1021/jm00189a006";"1979";"J Med Chem";"22";"251";"255";"";"";"";"";"";""
"CHEMBL3253428";"F";"Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [3H]uridine incorporation";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244343";"490537";"10.1021/jm00194a007";"1979";"J Med Chem";"22";"922";"926";"";"";"";"";"";""
"CHEMBL3256019";"B";"Binding affinity to calf thymus DNA assessed as change in melting temperature at 5 uM by spectrophotometer analysis";"Bos taurus";"14";"14";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3244385";"690999";"10.1021/jm00206a003";"1978";"J Med Chem";"21";"732";"737";"";"";"";"";"";""
"CHEMBL3529273";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3254890";"F";"Inhibition of DNA synthesis in mouse L1210 cells compound preincubated for 3 hrs followed by [3H]thymidine addition measured after 1 hr by scintillation counting";"Mus musculus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3243937";"628003";"10.1021/jm00201a009";"1978";"J Med Chem";"21";"280";"283";"";"";"";"";"";""
"CHEMBL4303085";"F";"AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).";"Chlorocebus sabaeus";"57";"57";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215035";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"917";"919";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4194066";"F";"Cytotoxicity in human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4190345";"28923382";"10.1016/j.ejmech.2017.09.009";"2017";"Eur J Med Chem";"140";"141";"154";"";"";"";"";"";""
"CHEMBL3215169";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ";"";"3383";"3728";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354282";"F";"PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ";"";"9957";"10019";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137735";"T";"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137740";"T";"Proposed mechanism(s) of liver damage. [column 'MEC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137730";"T";"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2345823";"F";"Cytotoxicity against mouse DA-3 cells assessed as reduction in cell viability at 20 uM after 180 mins by XTT assay relative to control";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"DA-3 cell line";"";"CHEMBL2331546";"24900668";"10.1021/ml3002852";"2013";"ACS Med Chem Lett";"4";"323";"328";"";"";"";"";"";""
"CHEMBL3137737";"T";"Presence of at least one case with successful reintroduction. [column 'REINT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137725";"T";"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL4303091";"T";"Selectivity ratio: ratio of AUC (viral infection %) of SARS-CoV-2 in the Vero E6 cell line compared to AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.";"";"57";"57";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"SARS-CoV-2 Screening Data 2020-21";"";"";"";"Vero E6";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231601";"F";"Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 4 mg/kg, ip on days 5, 9 and 13 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3253422";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, po q4d administered on days 5, 9 and 13 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244343";"490537";"10.1021/jm00194a007";"1979";"J Med Chem";"22";"922";"926";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2149456";"F";"Resistance ratio of IC50 for multidrug-resistant Leishmania tropica and IC50 for wild type Leishmania tropica LRC";"Leishmania tropica";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5666";"";"";"";"";"CHEMBL2146369";"22939695";"10.1016/j.bmcl.2012.07.100";"2012";"Bioorg Med Chem Lett";"22";"6272";"6275";"";"";"";"";"";""
"CHEMBL2390674";"B";"Induction of tau K19 (unknown origin) disaggregation assessed as decrease in paired helical filament formation measured disassembly-inducing half maxima after 10 days by thioflavin S fluorescence assay in presence of heparin";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2385058";"23484434";"10.1021/jm3017317";"2013";"J Med Chem";"56";"4135";"4155";"";"";"";"";"";""
"CHEMBL4303089";"T";"AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.";"Chlorocebus sabaeus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529280";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3418667";"F";"Induction of apoptosis in human HepG2 cells after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL3508168";"A";"Terminal half-life ratio of 13-dihydrometabolite of daunorubicin to daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3418661";"F";"Induction of apoptosis in human HL60 cells after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL2328700";"F";"Cytotoxicity against mouse L5178Y cells expressing p-gp after 24 hrs by MTT assay";"Mus musculus";"1";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL2321804";"23199479";"10.1016/j.bmc.2012.10.041";"2013";"Bioorg Med Chem";"21";"166";"177";"";"";"";"";"";""
"CHEMBL3562120";"F";"PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282189";"B";"Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 6.2 by stop-flow technique in presence of 5 mM Na+ ionic strength";"Salmonidae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"8015";"";"";"";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"";"";"";"";"";""
"CHEMBL4399803";"A";"Cytotoxicity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL4396939";"31431363";"10.1016/j.bmcl.2019.08.021";"2019";"Bioorg Med Chem Lett";"29";"126617";"126617";"";"";"";"";"";""
"CHEMBL3285222";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.12 mg/kg, ip qd administered for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272356";"176359";"10.1021/jm00225a011";"1976";"J Med Chem";"19";"395";"398";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3231682";"F";"Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 2 mg/kg, ip on day 5 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3232567";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1.56 mg/kg, ip administered as qd for 1 to 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"standard_type:DOSE standard_relation:= standard_value:1.56 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529277";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3252974";"F";"Antitumor activity against mouse P388 cells allografted in CDF/BDF mouse assessed as survival time at 8 mg/kg, ip administered as qd on day 5, 9, 13";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4352980";"T";"Hepatotoxicity in SCID mouse xenografted with human HT-29 cells assessed as decrease in liver weight at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured at 23 days post inoculation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL4027183";"A";"Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by Alamar blue assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL4024766";"29190092";"10.1021/acs.jmedchem.7b01447";"2017";"J Med Chem";"60";"10188";"10204";"";"";"";"";"";""
"CHEMBL3508199";"A";"AUC of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4352924";"F";"Cytostatic activity against human HepG2 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4350976";"31100648";"10.1016/j.ejmech.2019.05.016";"2019";"Eur J Med Chem";"176";"105";"116";"";"";"";"";"";""
"CHEMBL748163";"F";"Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 16 mg/kg";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P-388";"";"CHEMBL1121844";"7252976";"10.1021/jm00138a005";"1981";"J Med Chem";"24";"669";"673";"standard_type:DOSE standard_relation:= standard_value:16.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2025739";"B";"Inhibition of HDAC in human DU145 cells assessed as upregulation of p21waf1 protein expression at 0.1 uM after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL2025279";"B";"Inhibition of HDAC1 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2021781";"22260166";"10.1021/jm200799p";"2012";"J Med Chem";"55";"1465";"1477";"";"";"";"";"";""
"CHEMBL3256155";"F";"Inhibition of DNA synthesis in mouse L1210 cells";"Mus musculus";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3256154";"F";"Selectivity ratio of ED50 for inhibition of DNA synthesis in mouse L1210 cells to ED50 for inhibition of RNA synthesis in mouse L1210 cells";"Mus musculus";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244252";"490536";"10.1021/jm00194a005";"1979";"J Med Chem";"22";"912";"918";"";"";"";"";"";""
"CHEMBL3527758";"A";"Fraction absorbed in human";"Homo sapiens";"62";"62";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529296";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL2114889";"F";"PubChem BioAssay. qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion. (Class of assay: confirmatory) ";"Homo sapiens";"35";"35";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3057686";"A";"Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as residual activity at 0.8 uM";"Sus scrofa";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"CHEMBL3833141";"Heart left ventricle";"";"";"CHEMBL3045450";"None";"10.1007/s00044-008-9154-8";"2009";"Med Chem Res";"18";"629";"638";"";"";"";"";"";""
"CHEMBL3562139";"F";"PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562021";"F";"PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3418663";"F";"Induction of apoptosis in human HL60R cells expressing p-glycoprotein after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HL60R";"";"CHEMBL3414568";"25874335";"10.1016/j.ejmech.2015.04.004";"2015";"Eur J Med Chem";"96";"98";"104";"";"";"";"";"";""
"CHEMBL3231600";"F";"Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 8 mg/kg, ip on days 5, 9 and 13 relative to untreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3227922";"571021";"10.1021/jm00190a010";"1979";"J Med Chem";"22";"406";"411";"standard_type:DOSE standard_relation:= standard_value:8.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3561990";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ";"";"2189";"2208";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL741667";"F";"Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as % tumor volume change from initial by day 30";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132380";"10479297";"10.1021/jm990166e";"1999";"J Med Chem";"42";"3657";"3667";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3215292";"F";"PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen.   (Class of assay: confirmatory) ";"";"235";"242";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076080";"F";"TP_TRANSPORTER: transepithelial transport of Rhodamine 123 in the presence of Daunorubicin (Daunomycin) at a concentration of 80uM in MDR1-expressing MDCK cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2074322";"15067695";"10.1002/jps.20046";"2004";"J Pharm Sci";"93";"1185";"1194";"";"";"";"";"";""
"CHEMBL3529287";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL2025164";"F";"Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-9 to 10'-6 M after 72 hrs by cell counting method relative to untreated control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MONO-MAC-6";"";"CHEMBL2021806";"22480495";"10.1016/j.ejmech.2012.03.016";"2012";"Eur J Med Chem";"52";"173";"183";"";"";"";"";"";""
"CHEMBL3282194";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as tumor growth inhibition at 0.25 to 10 mg/kg";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272314";"1255661";"10.1021/jm00225a008";"1976";"J Med Chem";"19";"381";"384";"standard_type:DOSE standard_relation:None standard_value:None standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3231208";"T";"Genotoxicity in Salmonella typhimurium TA98 at >8 ug/plate by Ames test";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"TA98";"Scientific Literature";"90371";"";"";"";"";"CHEMBL3227991";"423181";"10.1021/jm00187a009";"1979";"J Med Chem";"22";"36";"39";"";"";"";"";"";""
"CHEMBL3561996";"F";"PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"233";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4393039";"A";"Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4392829";"30902399";"10.1016/j.bmc.2019.03.028";"2019";"Bioorg Med Chem";"27";"1804";"1817";"";"";"";"";"";""
"CHEMBL4303083";"F";"IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).";"Chlorocebus sabaeus";"57";"57";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4303086";"T";"Cytotoxicity of compound against Vero E6 cells by MTT assay.";"Chlorocebus sabaeus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3253426";"B";"Binding affinity to DNA (unknown origin) assessed as DNA interaction by measuring change in melting temperature";"Not specified";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3244343";"490537";"10.1021/jm00194a007";"1979";"J Med Chem";"22";"922";"926";"";"";"";"";"";""
"CHEMBL3253044";"A";"Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL3508177";"A";"Volume of distribution of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog";"Canis lupus familiaris";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Beagle";"FDA Approval Packages";"9615";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3508140";"None";"None";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DATASET standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2468087.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None | standard_type:N standard_relation:= standard_value:2.0 standard_units:None comments:None | standard_type:NORMALISED_BY standard_relation:None standard_value:None standard_units:None comments:None | standard_type:NORMALISED_TO standard_relation:= standard_value:1.0 standard_units:mg.Kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:STUDY_DOSING_DUR standard_relation:= standard_value:4.0 standard_units:Week comments:None | standard_type:STUDY_ID standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
